RESOURCES


home.aspx
   
Pharma Quality Control Testing PHARMA QUALITY CONTROL TESTING

whitepaper

Oct 09, 2019

Quality control (QC) plays a major role in the development of safe, highquality pharmaceutical products. This Pharmaceutical Technology/ Spectroscopy eBook on Pharma Quality Control Testing helps laboratories ensure they are up to date on the latest tools and techniques for achieving precise and eff...

Read More

Achieving faster formulation of solid oral dosage ACHIEVING FASTER FORMULATION OF SOLID ORAL DOSAGE

whitepaper

Oct 04, 2019

This whitepaper explores both of these two principle approaches and is broadly broken-down into two areas.

Read More

ADAPTING A REGULATORY FRAMEWORK FOR THE EMERGING CANNABIS INDUSTRY ADAPTING A REGULATORY FRAMEWORK FOR THE EMERGING CANNABIS INDUSTRY

whitepaper

Oct 01, 2019

The diversity of products that contain cannabis means that a “one-size-fits-all” regulatory framework would be ineffective.

Read More

Digital Therapeutics: pharma’s threat or opportunity DIGITAL THERAPEUTICS: PHARMA’S THREAT OR OPPORTUNITY

whitepaper

Sep 30, 2019

The DTx market is like the early days of the biologics revolution. “We are right at the beginning – it is a whole new therapeutic modality and we have the opportunity to create upwards of 100 products to increase efficacy across a range of disease conditions”. But does it represent...

Read More

Pharma’s Transformation through Automation PHARMA’S TRANSFORMATION THROUGH AUTOMATION

whitepaper

Sep 27, 2019

How your staff can be relieved from drudgery, augment their capacity, and unleash creativity with Robotic Process Automation (RPA) in life sciences

Read More

Common Laboratory Techniques in the Drug Discovery Workflow COMMON LABORATORY TECHNIQUES IN THE DRUG DISCOVERY WORKFLOW

whitepaper

Sep 18, 2019

The characterization of novel therapeutics involves many chemical processes. A typical workflow of methods that are frequently carried out during drug discovery is depicted below.

Read More

Moving Molecules into Medicines MOVING MOLECULES INTO MEDICINES

whitepaper

Sep 13, 2019

The pharmaceutical R&D ecosystem relies on effective collaboration between internal and external stakeholders to collect, analyze, and share data in a secure, compliant, and efficient manner.

Read More

Artificial Intelligence ARTIFICIAL INTELLIGENCE'S POTENTIAL ROLE IN THE REVOLUTION OF DRUG DISCOVERY

whitepaper

Sep 10, 2019

Modern drug discovery is a complicated process that requires identification of disease targets, bioactive substances that act upon those targets, and finally optimization of those drug candidates.

Read More

Optimizing Operations in Multiproduct Pharma Manufacturing Facilities OPTIMIZING OPERATIONS IN MULTIPRODUCT PHARMA MANUFACTURING FACILITIES

whitepaper

Sep 03, 2019

Facilities flexible enough to manufacture multiple products have become a cornerstone of our industry, crucial for meeting changing and challenging market and regulatory expectations.

Read More

Ophthalmic Drug Delivery for Retinal Disorders OPHTHALMIC DRUG DELIVERY FOR RETINAL DISORDERS

whitepaper

Aug 31, 2019

Delivery of therapeutics to the human eye is one of the most interesting endeavors a formulator can take on, but also one of the most challenging.

Read More

NEEDLE FREE INJECTION TECHNOLOGY- AN OVERVIEW NEEDLE FREE INJECTION TECHNOLOGY- AN OVERVIEW

whitepaper

Aug 29, 2019

Injuries which occur on regular basis in day today routine of hospital and healthcare setups. The Plethora of new injectable products has created new opportunities for physicians to treat areas previously thought to be not reachable.

Read More

Cost Savings And Business Benefits Of The Madison Logic Platform COST SAVINGS AND BUSINESS BENEFITS OF THE MADISON LOGIC PLATFORM

whitepaper

Aug 29, 2019

In account-based marketing (ABM) campaigns, B2B marketers can target contacts with pinpoint accuracy through programmatic advertising. They can also create personalized content for buyers at every stage of the purchase journey. However, three challenges remain: Are businesses targeting the right con...

Read More

OVERCOMING DRUG SHORTAGES WITH TECH OVERCOMING DRUG SHORTAGES WITH TECH

whitepaper

Aug 25, 2019

Medication shortages come with a substantial cost to pharmaceutical companies—loss of revenue, provider loyalty, and brand reputation pose significant and detrimental threats to business. Currently, the United States Food and Drug Administration (U.S. FDA) lists over 150 drug shortages, costin...

Read More

WHY AI? HOW LANGUAGE & AI SERVICES GO HAND-IN-HAND WHY AI? HOW LANGUAGE & AI SERVICES GO HAND-IN-HAND

whitepaper

Aug 21, 2019

In practice, of course, things are more complicated. Effective translation necessitates a nuanced understanding of (at least) two languages and cultures, both source and target. It requires an understanding of the original content’s goals. It mandates a fluency in tone and subtext as well as v...

Read More

A BUYER’S GUIDE FOR LOCALIZATION SERVICES: A BUYER’S GUIDE FOR LOCALIZATION SERVICES:

whitepaper

Aug 21, 2019

Your localization partner is going to do a deep-dive into your business—so start by diving deep into theirs. Are they an industry-leader with 20 years of experience or a relative newcomer? Will they speak Samoan, Uzbek, or Swahili (and all your customers’ languages)? Can they deliver on-...

Read More

Patient Management Program (PMP) Overview PATIENT MANAGEMENT PROGRAM (PMP) OVERVIEW

whitepaper

Aug 19, 2019

Benzer Pharmacy Specialty Pharmacy Patient Management Program proactively works with patients in a number of chronic disease states to provide specialty pharmaceuticals and therapy management support services to obtain optimal therapeutic outcomes thus avoiding adverse drug events and unnecessary co...

Read More

Launching Global Clinical Trials LAUNCHING GLOBAL CLINICAL TRIALS

whitepaper

Aug 19, 2019

This white paper highlights the language challenges found in a global clinical trial and offers a number of best practices for managing the translation effort. Failure to adequately plan for translation introduces several new risk factors that must be considered in today’s highly-competitive p...

Read More

USING CONTENT MARKETING TO GENERATE DEMAND, CREATE NEW AUDIENCES USING CONTENT MARKETING TO GENERATE DEMAND, CREATE NEW AUDIENCES

whitepaper

Aug 14, 2019

Content—and how brands use it to interact with buyers at all stages of the engagement journey—has fundamentally reshaped every business’ go-to-market strategy. This shift has been particularly challenging for “top-of-the-funnel” demand generation marketers, most of who ...

Read More

COPAY ACCUMULATOR PROGRAMS & PHARMA: WHAT’S NEXT? COPAY ACCUMULATOR PROGRAMS & PHARMA: WHAT’S NEXT?

whitepaper

Aug 02, 2019

Dynamics between pharma and the market-based healthcare sector it serves have invariably been complex, with one of the biggest drivers of that complexity being effective management of patient demand and payer systems.

Read More

The impact of B vitamins on nonsteroidal anti-inflammatory drug efficacy and safety THE IMPACT OF B VITAMINS ON NONSTEROIDAL ANTI-INFLAMMATORY DRUG EFFICACY AND SAFETY

whitepaper

Jul 25, 2019

Drug-nutrient interactions (DNIs) are defined as physical, chemical, physiologic or pathophysiologic relationships between a drug and a nutrient present in a food or a supplement.3

Read More

Artificial Intelligence ARTIFICIAL INTELLIGENCE'S POTENTIAL ROLE IN THE REVOLUTION OF DRUG DISCOVERY

whitepaper

Jul 24, 2019

Modern drug discovery is a complicated process that requires identification of disease targets, bioactive substances that act upon those targets, and finally optimization of those drug candidates. Each stage of the process is time consuming and costly with no guarantee of success.

Read More

Real-Time Temperature Monitoring for Pharma Cold Chain Logistics REAL-TIME TEMPERATURE MONITORING FOR PHARMA COLD CHAIN LOGISTICS

whitepaper

Jul 23, 2019

When it comes to safely and securely transporting high value pharmaceutical products, the stakes couldn’t be higher. Not only is a single consignment of high value drugs potentially worth upwards of $50 million, but, for those patients in need of these drugs, ensuring these products arrive on ...

Read More

5 Ways Artificial Intelligence Is Changing the Pharma and Healthcare Industries 5 WAYS ARTIFICIAL INTELLIGENCE IS CHANGING THE PHARMA AND HEALTHCARE INDUSTRIES

whitepaper

Jul 22, 2019

Forbes predicts that AI in healthcare will top US$1.7 billion by the end of the year. Download our free whitepaper today and learn the top 5 ways artificial intelligence is driving exciting change that will improve patient outcomes.

Read More

IMPACT ON COMBINATION PRODUCTS AND COMPANION DIAGNOSTICS IMPACT ON COMBINATION PRODUCTS AND COMPANION DIAGNOSTICS

whitepaper

Jul 19, 2019

With the end of the Medical Device Regulation’s (MDR) transition period looming (May 26th, 2020), manufacturers of drug device combination products or companion diagnostics are under heightened time pressure to comply with the new Regulation. Any company manufacturing or distributing these pro...

Read More

IoT Technologies & Informatics Integration in Pharmaceuticals IOT TECHNOLOGIES & INFORMATICS INTEGRATION IN PHARMACEUTICALS

whitepaper

Jul 17, 2019

IoT technologies are proving to be of great benefit to pharmaceutical organizations that aim to innovate. The ability to integrate informatics solutions in pharmaceutical environments enables organizations to streamline and standardize connectivity from previously disparate equipment, networks, and ...

Read More

PHARMACOVIGILANCE AND RISK MANAGEMENT CONSIDERATION FOR RARE DISEASE GENE THERAPIES PHARMACOVIGILANCE AND RISK MANAGEMENT CONSIDERATION FOR RARE DISEASE GENE THERAPIES

whitepaper

Jul 17, 2019

The development of a pharmacovigilance and risk management system to support a gene therapy for a rare genetic disease requires consideration of the specific challenges and nuances that novel therapies present throughout the lifetime of the product.

Read More

Compete and Win in the Age of Account Based Buying COMPETE AND WIN IN THE AGE OF ACCOUNT BASED BUYING

whitepaper

Jul 15, 2019

If you’re on a B2B revenue team, it’s likely your Marketing and Sales teams are experiencing some angst these days when it comes to understanding how prospects and customers want to interact with your company. On one hand customers seem to want ultra-personalized attention on every chann...

Read More

Top 10 Best Selling Drugs of 2018 Fund US and EU Pharma RD TOP 10 BEST SELLING DRUGS OF 2018 FUND US AND EU PHARMA RD

whitepaper

Jul 15, 2019

Our latest white paper discusses the dynamics and marketing of 2018’s top selling drugs, chief therapeutic areas, and biosimilar erosion, with a deeper dive into the top three drugs: Humira, Revlimid, and Opdivo.

Read More

Nuclear Receptors & Endocrine / Metabolic Disruption NUCLEAR RECEPTORS & ENDOCRINE / METABOLIC DISRUPTION

whitepaper

Jul 12, 2019

From our understanding today, there are many environmental chemicals that carry the potential to affect the endocrine system. Known as endocrine disrupting chemicals (EDCs), these compounds alter drug and xenobiotic metabolic processes and can interfere with the production, release, metabolism, and ...

Read More

How Does Pharma Learn To Speak “Patient”? HOW DOES PHARMA LEARN TO SPEAK “PATIENT”?

whitepaper

Jul 11, 2019

This eBook takes readers through an example of discourse analysis of a patient community on Inspire.  In the process, author Kathryn Ticknor demonstrates how the language of patients is a different language from “medicalese,” the language of medicine.  Her insights are a first ...

Read More

Oxetanes in Drug Discovery OXETANES IN DRUG DISCOVERY

whitepaper

Jul 10, 2019

Oxetanes have been employed to improve drugs’ physiochemical properties. Currently, over a dozen oxetane-containing drugs have progressed to different phases of clinical trials. Once one of them gains the FDA approval, the enthusiasm toward its utility in drug discovery will grow exponentially...

Read More

Smart Cleanroom: the innovative solution to reduce HVAC energy consumption in classified areas SMART CLEANROOM: THE INNOVATIVE SOLUTION TO REDUCE HVAC ENERGY CONSUMPTION IN CLASSIFIED AREAS

whitepaper

Jul 10, 2019

Pharmaceutical companies face the challenge of reducing production costs without negatively affecting the quality of the finished products. HVAC systems are one of the main energy consumers in pharma facilities especially in sterile manufacturing. Therefore energy savings are particularly noticeable...

Read More

Six essential ways to improve your pharmaceutical quality system SIX ESSENTIAL WAYS TO IMPROVE YOUR PHARMACEUTICAL QUALITY SYSTEM

whitepaper

Jul 10, 2019

Pharmaceutical operations are inherently complex, and the bar seems to get higher with each passing year and with the issuing of new guidance. Staying current is not easy and managing the inherent, ever-growing complexity can be a serious challenge.

Read More

Russia: Serialization and Aggregation of Medications Becoming Mandatory. RUSSIA: SERIALIZATION AND AGGREGATION OF MEDICATIONS BECOMING MANDATORY.

whitepaper

Jul 10, 2019

Counterfeit products naturally pose a major problem in the pharmaceutical sector. This affects brand-name and generic products as well as OTC (over the counter) products. Counterfeiters not only bring imitation medication into circulation through non-authorized pharmacies and online portals, but als...

Read More

PHARMACOVIGILANCE AUTOMATION HAS ARRIVED PHARMACOVIGILANCE AUTOMATION HAS ARRIVED

whitepaper

Jul 10, 2019

The rising cost of pharmacovigilance (PV) tasks has been an ongoing challenge for the pharma industry. Many companies have chosen to shift these tasks to overseas vendors to take advantage of cheaper labor without compromising quality.

Read More

AI-Powered Biomedical Literature Discovery Supporting Science-Based Business Decisions AI-POWERED BIOMEDICAL LITERATURE DISCOVERY SUPPORTING SCIENCE-BASED BUSINESS DECISIONS

whitepaper

Jul 09, 2019

Artificial intelligence (AI) is crucial for discovering, exploring, and understanding this textual information and a critical tool for developing new drugs, designing clinical trials, receiving drug approvals and more.

Read More

IoT Technologies & Informatics Integration in Pharmaceuticals IOT TECHNOLOGIES & INFORMATICS INTEGRATION IN PHARMACEUTICALS

whitepaper

Jul 09, 2019

IoT technologies are proving to be of great benefit to pharmaceutical organizations that aim to innovate. The ability to integrate informatics solutions in pharmaceutical environments enables organizations to streamline and standardize connectivity from previously disparate equipment, networks, and ...

Read More

The SiriusDecisions B-to-B Buying Decision Process Framework THE SIRIUSDECISIONS B-TO-B BUYING DECISION PROCESS FRAMEWORK

whitepaper

Jul 08, 2019

Decisionmaking is a cognitive process defined by psychologists as the selection of a course of action from multiple alternatives (e.g. what to eat, where to shop). John Dewey, the pragmatic philosopher and psychologist, introduced the first decision process framework for consumer buying in his book ...

Read More

DIA & Vifor Pharma DIA & VIFOR PHARMA

whitepaper

Jul 08, 2019

Our latest white paper discusses the dynamics and marketing of 2018’s top selling drugs, chief therapeutic areas, and biosimilar erosion, with a deeper dive into the top three drugs: Humira, Revlimid, and Opdivo.

Read More

The Medicine Maker THE MEDICINE MAKER

whitepaper

Jun 29, 2019

The cannabis business is booming and pharma is looking to get in on the action with new business models and potential new drugs derived from the cannabis plant.

Read More

Linking Pharma Manufacturing: CDMOs, Blockchain & Distributed Ledger Technologies (DLT) LINKING PHARMA MANUFACTURING: CDMOS, BLOCKCHAIN & DISTRIBUTED LEDGER TECHNOLOGIES (DLT)

whitepaper

Jun 26, 2019

The term blockchain is most often associated with cryptocurrencies such as Bitcoin, but the technology and its implications could have a more far-reaching impact on other industries including pharmaceutical manufacturing. Contract drug manufacturing organizations (CDMOs) and pharmaceutical developer...

Read More

Positioning Your Pharmaceutical Lab for Success POSITIONING YOUR PHARMACEUTICAL LAB FOR SUCCESS

whitepaper

Jun 26, 2019

A pharma lab needs regulatory documentation, while a diagnostics lab requires advanced tracking of biospecimens. Traditionally, each would begin with the same basic building blocks: a Laboratory Information Management System (LIMS) with standalone point solutions such as an Electronic Laboratory Not...

Read More

How Dermatology Research Gaps Represent Untapped Markets for Pharmaceutical Companies HOW DERMATOLOGY RESEARCH GAPS REPRESENT UNTAPPED MARKETS FOR PHARMACEUTICAL COMPANIES

whitepaper

Jun 25, 2019

Gaps in dermatological research present potentially lucrative market opportunities for pharmaceutical companies. Patients that suffer from skin conditions and diseases also benefit. Effective treatments relieve irritating, chronic, and often painful symptoms, which improves their quality of life and...

Read More

A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis A DECADE IN REVIEW: ONCOLOGY TRIAL BENCHMARKS AND SPONSOR ANALYSIS

whitepaper

Jun 25, 2019

The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the a...

Read More

Benefits of 2D-LC/MS/MS in Pharmaceutical Bioanalytics BENEFITS OF 2D-LC/MS/MS IN PHARMACEUTICAL BIOANALYTICS

whitepaper

Jun 25, 2019

This application demonstrates the 2D-LC/MS/MS analysis of cell supernatants from an in vitro cell suspension-based assay. Superior separation by 2D-LC allowed the analysis of 16 target metabolites within 35 minutes.

Read More

How to optimise pharma’s digital HCP engagement HOW TO OPTIMISE PHARMA’S DIGITAL HCP ENGAGEMENT

whitepaper

Jun 24, 2019

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a company can offer and an HCP’s needs.

Read More

DIRECTIVE CONSULTING PORTFOLIO DIRECTIVE CONSULTING PORTFOLIO

whitepaper

Jun 24, 2019

We believe that data-driven marketing shouldn’t be confusing. Every company should know what works for their campaigns in order to make more ROI-driven decisions. At Directive, we not only craft customized campaigns for your unique marketing objectives - we exceed those objectives and truly re...

Read More

New Insights in Computational Methods for Pharmacovigilance NEW INSIGHTS IN COMPUTATIONAL METHODS FOR PHARMACOVIGILANCE

whitepaper

Jun 24, 2019

Today’s surge of big data coming from multiple sources is raising the stakes that pharmacovigilance has to win, making evidence synthesis a more and more robust approach in the field. In this scenario, many scholars believe that new computational methods derived from data mining will effective...

Read More

Computational Infrastructure for Modern Pharmaceuticals COMPUTATIONAL INFRASTRUCTURE FOR MODERN PHARMACEUTICALS

whitepaper

Jun 19, 2019

This paper, authored by Alireza Shabani, Founder & CEO of Qulab, describes the necessary computational architecture for pharmaceutical firms to accelerate R&D and drug discovery, especially utilizing special purpose silicon and quantum processors.

Read More

Weighing in Pharmaceutical Quality Control according to U.S. Pharmacopeia WEIGHING IN PHARMACEUTICAL QUALITY CONTROL ACCORDING TO U.S. PHARMACOPEIA

whitepaper

Jun 19, 2019

USP Chapter 41 weighing requirements are mandatory in a Pharmaceutical Quality Control (QC) laboratory, where weighing is a fundamental step in almost every workflow. Typically, weighing of a sample or standard is the first step in the analytical procedure, followed by subsequent dilution and analys...

Read More

Weighing in pharmaceutical quality control according to US Pharmacopeia WEIGHING IN PHARMACEUTICAL QUALITY CONTROL ACCORDING TO US PHARMACOPEIA

whitepaper

Jun 19, 2019

This white paper fully explains the requirements of the 2019 versions of the USP General Chapters 41 and 1251 and provides guidance on how to put these requirements into practice. Weighing according to USP requirements ensures that consistently high quality weighing results are achieved and applies ...

Read More

Benefits And Challenges Of Driving Modernization In Vaccine Development BENEFITS AND CHALLENGES OF DRIVING MODERNIZATION IN VACCINE DEVELOPMENT

whitepaper

Jun 11, 2019

Vaccines have historically been a challenging corner of the industry, as they are highly-regulated and require a greater investment of time and money to develop than other biologics.

Read More

Free Drug & Alcohol Program FREE DRUG & ALCOHOL PROGRAM

whitepaper

Jun 11, 2019

The cost of employee substance abuse adds up quickly, and it is vital for your company to detect and deter drug and alcohol abuse among employees.

Read More

Pharma RD Annual Review 2019 Supplement New Active Substances Launched During 2018 PHARMA RD ANNUAL REVIEW 2019 SUPPLEMENT NEW ACTIVE SUBSTANCES LAUNCHED DURING 2018

whitepaper

Jun 11, 2019

Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successf...

Read More

Custom manufacturing in pharma CUSTOM MANUFACTURING IN PHARMA

whitepaper

Jun 11, 2019

Contract development and manufacturing organisations (CDMOs) in the pharmaceutical world are on the up. They benefit from an increasing number of companies that outsource parts of their production to external service providers.

Read More

COMPETITIVE INTELLIGENCE IN AN AGILE WORLD COMPETITIVE INTELLIGENCE IN AN AGILE WORLD

whitepaper

Jun 09, 2019

This thought piece explores the concept of agile working for the pharma world, delving into the opportunities and challenges that arise for CI teams and managers as working environments adapt to find success in a more dynamic, uncertain, and fast-paced environment.

Read More

Cubis® II pharma compliant by design CUBIS® II PHARMA COMPLIANT BY DESIGN

whitepaper

Jun 06, 2019

Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable.

Read More

X-Ray Inspection More Than Just Contamination Detection X-RAY INSPECTION MORE THAN JUST CONTAMINATION DETECTION

whitepaper

Jun 03, 2019

This white paper looks at the potential of x-ray inspection to solve a wide range of product safety and quality control issues typically found within food and pharmaceutical manufacturing. It explores how x-ray inspection can detect faulty products before they leave the factory, avoiding product rec...

Read More

Process Effects On Drug Product Quality In Pharmaceutical Manufacturing—A Validated Measurement Process PROCESS EFFECTS ON DRUG PRODUCT QUALITY IN PHARMACEUTICAL MANUFACTURING—A VALIDATED MEASUREMENT PROCESS

whitepaper

May 30, 2019

Pharmaceutical manufacturing is an industry laden with many challenges and risks due to the life-changing nature of its products—drugs that can affect millions of human lives. Manufacturers perform immensely complex research and testing daily, while facing economic challenges and regulatory re...

Read More

Better ways to handle tablets using IBCs BETTER WAYS TO HANDLE TABLETS USING IBCS

whitepaper

May 30, 2019

It is common to find Intermediate Bulk Containers (IBCs) being used for handling powders and granules in solid dosage manufacturing processes, from initial Dispensing through to Tablet Compression or Capsule Filling. The benefits of using IBCs for efficient and flexible materials handling at this st...

Read More

Solid Dose Trends 2019 SOLID DOSE TRENDS 2019

whitepaper

May 29, 2019

The buzz may be around biologics, but the oral solid dose sector is still going strong

Read More

BETTER BUILDINGS FOR BETTER PHARMACEUTICAL PRODUCTION BETTER BUILDINGS FOR BETTER PHARMACEUTICAL PRODUCTION

whitepaper

May 28, 2019

Embracing and investing in new technologies is one way to get ahead, and adopting lean, efficient manufacturing procedures is another. At a fundamental level, achieving efficiency can start at the outset of a project by considering the very design of a production facility. Careful planning can cut c...

Read More

Biopharma Manufacturing Trends BIOPHARMA MANUFACTURING TRENDS

whitepaper

May 27, 2019

The biopharma sector has seen incredible growth in recent decades, with growth the major long-term trend. Total annual revenue has increased from about $4.4 billion in 1990 to now about $275 billion, an increase of 6,250 percent, with biopharmaceuticals now more than 25 percent of the total pharmace...

Read More

Help Keep Pharmaceuticals Safe: Metal Detection Overview And Guidelines HELP KEEP PHARMACEUTICALS SAFE: METAL DETECTION OVERVIEW AND GUIDELINES

whitepaper

May 27, 2019

Pharmaceutical manufacturing is not immune to metal-object contamination, it is important to discuss ways to effectively incorporate metal detection into the production or packaging processes when practicable.

Read More

Comparative human in-vivo study of an immediate release tablet over-encapsulated by gelatin and hydroxypropyl methyl cellulose capsules COMPARATIVE HUMAN IN-VIVO STUDY OF AN IMMEDIATE RELEASE TABLET OVER-ENCAPSULATED BY GELATIN AND HYDROXYPROPYL METHYL CELLULOSE CAPSULES

whitepaper

May 22, 2019

Rapid and consistent in-vivo drug dissolution is critical for drug absorption. In-vitro dissolutions tests are used to predict in-vivo disintegration and dissolution properties of drug products. The invitro disintegration and dissolution times of tablets and capsules can vary significantly based on ...

Read More

IDENTIFYING PRODUCTS FOR DRUG DEVELOPMENT PROGRAMS IDENTIFYING PRODUCTS FOR DRUG DEVELOPMENT PROGRAMS

whitepaper

May 13, 2019

Assume a generic drug company, let’s call them AB Generics, Inc., always targets the introduction of its generic drugs when the reference product comes off patent.

Read More

Global Science & Technology Trends Report: Vaccine R&D GLOBAL SCIENCE & TECHNOLOGY TRENDS REPORT: VACCINE R&D

whitepaper

May 13, 2019

Vaccines and vaccination efforts have effectively prevented many life-threatening or debilitating infectious diseases and are regarded as one of the greatest achievements in the field of public health.

Read More

Protecting Critical Care Drugs PROTECTING CRITICAL CARE DRUGS

whitepaper

May 06, 2019

The growth of injectable critical care therapeutics requires multi-layer protection and authentication solutions.

Read More

State of Pharma Manufacturing 2019 STATE OF PHARMA MANUFACTURING 2019

whitepaper

May 01, 2019

The past year was marked by shifting business models, more stringent quality requirements, technological improvements and mounting political pressures to solve pharma-related policy issues. How has the industry responded?

Read More

Demand forecasting in pharmaceutical supply chains: A case study DEMAND FORECASTING IN PHARMACEUTICAL SUPPLY CHAINS: A CASE STUDY

whitepaper

Apr 30, 2019

Demand forecasting plays a critical role in logistics and supply chain management. In the paper, state-of-art methods and key challenges in demand forecasting for the pharmaceutical industry are discussed. An integrated procedure for in-market product demand forecasting and purchase order generation...

Read More

Safety profile of the analgesic Trezix, containing the mild opioid dihydrocodeine SAFETY PROFILE OF THE ANALGESIC TREZIX, CONTAINING THE MILD OPIOID DIHYDROCODEINE

whitepaper

Apr 30, 2019

Sharp rises in opioid abuse and overdose rates in the United States over the past two decades have prompted much-needed review of prescription rates and ease of access to controlled substances.  Combatting these alarming trends requires assessing which opioids are more addictive and habit-formi...

Read More

Understanding data trust in Healthcare UNDERSTANDING DATA TRUST IN HEALTHCARE

whitepaper

Apr 29, 2019

For U.S. healthcare leaders, trusted data is more important than ever, as their organizations migrate from the fee-for-service model to value-based care. During this transition, healthcare organizations must weigh investments, risks, and trade-offs objectively with quantitative, trustworthy data.

Read More

ENDOZYME II GO recombinant Factor C assay: fast, easy andconsistent endotoxin testing ENDOZYME II GO RECOMBINANT FACTOR C ASSAY: FAST, EASY ANDCONSISTENT ENDOTOXIN TESTING

whitepaper

Apr 24, 2019

The vast majority of endotoxin tests for pharmaceuticals and medical devices, as well as their in-process intermediates and raw materials, are microplate-based. They require tedious reconstitution and dilution steps for preparation of Control Standard Endotoxin (CSE) dilutions and Positive Product C...

Read More

Solid Dosage and Excipients SOLID DOSAGE AND EXCIPIENTS

whitepaper

Apr 24, 2019

For many reasons from ease of administration to dosing accuracy to manufacturing efficiency pharmaceutical manufacturers prefer to formulate their APIs as solid dosage drugs, and particularly tablets. There is significant room, however, for improvement of tableting processes. Advances in tableting t...

Read More

Why drug manufacturing needs to become more flexible WHY DRUG MANUFACTURING NEEDS TO BECOME MORE FLEXIBLE

whitepaper

Apr 22, 2019

Digital transformation does not stop at the pharmaceutical industry. But until Pharma 4.0 can become socially acceptable, it will first and foremost be necessary to define globally uniform standards. This is going to take time. Time which the industry does not have in view of the speed of developmen...

Read More

Pipelines and Patients Drive Finished Dosage Opportunities PIPELINES AND PATIENTS DRIVE FINISHED DOSAGE OPPORTUNITIES

whitepaper

Apr 22, 2019

Efforts to ease patient burden with multi-API products and the increasing number of candidate products with low bioavailability are creating opportunities for contract manufacturing and development organizations (CDMOs) to create value with innovative, but complex, finished dosage formulations. Prov...

Read More

Hot Melt Extrusion for Oral Solid Dosage Forms HOT MELT EXTRUSION FOR ORAL SOLID DOSAGE FORMS

whitepaper

Apr 18, 2019

Approximately half of all marketed drugs are administered orally, mostly in solid forms such as tablets or capsules. However, many APIs suffer from poor water solubility which leads to slow dissolution rates in the gastrointestinal tract and poor oral bioavailability. Hot melt extrusion is an effici...

Read More

Pharmacogenomics Testing: Harnessing the Power of Genetic Data for Personalized Medicine PHARMACOGENOMICS TESTING: HARNESSING THE POWER OF GENETIC DATA FOR PERSONALIZED MEDICINE

whitepaper

Apr 17, 2019

A more personalized approach to medicine can save lives and reduce medication-related side effects.

Read More

Pharma PHARMA'S ROAD MAP TO PATIENT CENTRICITY

whitepaper

Apr 16, 2019

Over the past decade, the healthcare ecosystem has slowly moved toward the “triple aim”: better healthcare experiences, improved outcomes, and a slowing of the growth of overall healthcare costs. While many pharma companies have focused on educating and engaging patients to promote share...

Read More

Applications in Pharmaceutical Manufacturing APPLICATIONS IN PHARMACEUTICAL MANUFACTURING

whitepaper

Apr 16, 2019

The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefi ts in terms of effectiveness, minimal surface residue, and easier cleaning validation. Virtually any pharmaceutical manufacturing equipment — from tablet presses to a stainless steel mixing tanks — ca...

Read More

Benefits of Using High-Functionality Excipients in a Continuous Manufacturing Process BENEFITS OF USING HIGH-FUNCTIONALITY EXCIPIENTS IN A CONTINUOUS MANUFACTURING PROCESS

whitepaper

Apr 10, 2019

As pharmaceutical companies move increasingly toward changing production methods from batch to continuous processing, there is a need to re-evaluate the types and formulations of the excipients used. Within a continuous process, conventional monofunctional excipients must be added through individual...

Read More

Understand Market Access Trends in the US, Europe and Emerging Markets UNDERSTAND MARKET ACCESS TRENDS IN THE US, EUROPE AND EMERGING MARKETS

whitepaper

Apr 10, 2019

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets. With governments and private healthcare systems under increasing pressure to fund high-cost, innovative therapies, which often launch with limited clinical trial evid...

Read More

Horizons in HIV Drug Development – What’s Past is Prologue HORIZONS IN HIV DRUG DEVELOPMENT – WHAT’S PAST IS PROLOGUE

whitepaper

Apr 10, 2019

To better predict the future of HIV pharmaceuticals, we must understand the past – that’s the premise behind Horizons in HIV Drug Development – What’s Past is Prologue, the free whitepaper from Citeline, part of the Informa Pharma Intelligence suite of industry intelligence s...

Read More

Pharma 2020: Marketing the future Which path will you take? PHARMA 2020: MARKETING THE FUTURE WHICH PATH WILL YOU TAKE?

whitepaper

Apr 09, 2019

The social, demographic and economic context in which the pharmaceutical industry (Pharma) operates is changing dramatically, as we noted in “Pharma 2020: The vision”.

Read More

Best Practices for Sample Preparation and Lipid Extraction BEST PRACTICES FOR SAMPLE PREPARATION AND LIPID EXTRACTION

whitepaper

Apr 04, 2019

Lipids play a structural role in organisms, forming cells and organelles’ membranes. Due to their implication in widespread pathologies such as cancer or inflammation, they are gaining considerable interest within the scientific community.

Read More

Pharma 2020: Marketing the future
Which path will you take? PHARMA 2020: MARKETING THE FUTURE WHICH PATH WILL YOU TAKE?

whitepaper

Apr 04, 2019

The social, demographic and economic context in which the pharmaceutical industry (Pharma) operates is changing dramatically, as we noted in “Pharma 2020: The vision”, the White Paper PricewaterhouseCoopers* published in June 2007 (see sidebar, Seven major trends reshaping the pharmaceut...

Read More

Improving the efficiency of catalyst screening in drug substance development IMPROVING THE EFFICIENCY OF CATALYST SCREENING IN DRUG SUBSTANCE DEVELOPMENT

whitepaper

Apr 03, 2019

Herewith ACD/Labs presents their web-based software solution to the multiple challenges experienced in screening workflows; offering effective support for high-throughput catalyst screening.

Read More

Risk Management Programs for the
Pharmaceutical Industry RISK MANAGEMENT PROGRAMS FOR THE PHARMACEUTICAL INDUSTRY

whitepaper

Apr 02, 2019

The FDA’s cGMPs for the 21st Century: A Risk-Based Approach Initiative In early 2002, the Food and Drug Administration (FDA) announced their Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach initiative. According to the FDA position paper: “The FDA oversees the quality of ...

Read More

Embedding Time-Critical Scheduling In Drug Production EMBEDDING TIME-CRITICAL SCHEDULING IN DRUG PRODUCTION

whitepaper

Mar 31, 2019

Drug manufacturing is a multifaceted undertaking in which numerous parallel processes, activities and resources must be marshaled and reconciled within a high-pressure environment where human errors inevitably occur.

Read More

Pharmaceutical Patent Term Extension PHARMACEUTICAL PATENT TERM EXTENSION

whitepaper

Mar 27, 2019

A period of market exclusivity is critical for most novel pharmaceutical products and the duration of that exclusivity has a direct impact on the value of a pharmaceutical asset. There several forms of exclusivity that can apply to pharmaceutical products. This overview is a summary of one of them: ...

Read More

Pharma R&D Annual Review 2019 Supplement PHARMA R&D ANNUAL REVIEW 2019 SUPPLEMENT

whitepaper

Mar 21, 2019

Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2019 this supplement takes a look at the industry’s success stories of 2018 – the drugs which were launched on to the market for the first time during the year. Our survey focuses ex...

Read More

Genomic Analysis in the Age of Human Genome Sequencing GENOMIC ANALYSIS IN THE AGE OF HUMAN GENOME SEQUENCING

whitepaper

Mar 21, 2019

Affordable genome sequencing technologies promise to revolutionize the field of human genetics by enabling comprehensive studies that interrogate all classes of genome variation, genome-wide, across the entire allele frequency spectrum.

Read More

Leveraging Predictive Analytics for Pharmaceutical Innovation LEVERAGING PREDICTIVE ANALYTICS FOR PHARMACEUTICAL INNOVATION

whitepaper

Mar 20, 2019

Pharmaceutical companies aiming to develop innovative new therapies and treatments face many challenges. Without proper processes and systems in place, it is very difficult to replicate successful results, mitigate failures, reduce product variability and ultimately deliver a new therapy to market. ...

Read More

From Discovery to Production: Hybrid Silica Chromatography and the Pharmaceutical Industry FROM DISCOVERY TO PRODUCTION: HYBRID SILICA CHROMATOGRAPHY AND THE PHARMACEUTICAL INDUSTRY

whitepaper

Mar 15, 2019

This whitepaper aims to provide pharmaceutical researchers with a better understanding of the uses and benefits of hybrid silica-based supports in HPLC separations of drug compounds. In a quick, absorbing read that includes commentary from a number of experts in the field, readers can find out how h...

Read More

Biopharma Manufacturing Trends 2019 BIOPHARMA MANUFACTURING TRENDS 2019

whitepaper

Mar 14, 2019

How slow-motion trends are driving biopharma growth, the dangerous impact of unproven stem cell therapies and more. For over two decades, the biopharmaceutical manufacturing industry has created a body of industrial knowledge and institutional experience.

Read More

Unraveling the Complexities of Neurological Disease and Injury with Real-time Live-cell Analysis UNRAVELING THE COMPLEXITIES OF NEUROLOGICAL DISEASE AND INJURY WITH REAL-TIME LIVE-CELL ANALYSIS

whitepaper

Mar 12, 2019

The pathophysiology of neurological disease and injury is admittedly highly complex and temporally dynamic.  This poses a daunting challenge for the development and appropriate use of physiologically relevant models for investigative research.  Subtle fluctuations occur continually, and de...

Read More

Breaking new ground in digital content delivery for pharma BREAKING NEW GROUND IN DIGITAL CONTENT DELIVERY FOR PHARMA

whitepaper

Mar 12, 2019

It’s all too easy for pharmaceutical processes to slow marketing campaigns, rendering them unmanageable and ineffective, but a ground-breaking initiative is proving that digital content delivery can be timely, effective and drive a return-on-investment.

Read More

Exploring the Hallmarks of Cancer With Real-Time Live-Cell Analysis EXPLORING THE HALLMARKS OF CANCER WITH REAL-TIME LIVE-CELL ANALYSIS

whitepaper

Mar 11, 2019

Our understanding of tumor biology is constantly evolving and helps to shed new light on the behavior of many cancers as well as providing new pharmacological targets and treatment strategies. Over the past decade, there have been immense technological advances in the field of in vitro translational...

Read More

Accelerating Antibody Development with Automated Octet Assays ACCELERATING ANTIBODY DEVELOPMENT WITH AUTOMATED OCTET ASSAYS

whitepaper

Mar 11, 2019

Drug development and production are challenging, however, high throughput characterization systems can greatly accelerate discovery programs. Using a proprietary discovery and development platform technology, Avitide enables its partners to rapidly advance candidate molecules to the clinic and achie...

Read More

Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multiproduct Facility MANUFACTURING OF CYTOTOXIC AND NON-CYTOTOXIC DRUGS IN A MULTIPRODUCT FACILITY

whitepaper

Mar 10, 2019

When different drug products are produced in shared facilities, the potential for cross-contamination is always a concern that needs to be addressed.

Read More

IMPROVING T CELL FUNCTION IN THE SOLID TUMOR MICROENVIRONMENT IMPROVING T CELL FUNCTION IN THE SOLID TUMOR MICROENVIRONMENT

whitepaper

Mar 09, 2019

In recent years, cancer immunotherapies, in particular, immune checkpoint blockade and combination therapies, have demonstrated remarkable success in treating multiple refractory cancers. One such therapeutic approach prevents T cell exhaustion by blocking the PD-1/PD-L1 pathway, which has shown tum...

Read More

Flow Chemistry: A Scale-Up Solution For Modern API Development And Manufacturing FLOW CHEMISTRY: A SCALE-UP SOLUTION FOR MODERN API DEVELOPMENT AND MANUFACTURING

whitepaper

Feb 27, 2019

Once deemed an “experts-only” approach to chemical synthesis, flow chemistry is a cost-efficient technique growing in popularity that can increase safety and flexibility and improve product quality. However, not all chemical profiles perform better under flow conditions. Thus, you must k...

Read More

Healthcare 2030 the consumer at the center HEALTHCARE 2030 THE CONSUMER AT THE CENTER

whitepaper

Feb 26, 2019

The healthcare industry is facing major demographic changes that will dramatically impact which services are needed and how they are delivered.  As Millennials, Generation X, and Baby Boomers enter new life stages at the same time, there are simultaneous demands for lower cost, convenient care ...

Read More

Transformational Drivers in the Health System of the Future TRANSFORMATIONAL DRIVERS IN THE HEALTH SYSTEM OF THE FUTURE

whitepaper

Feb 20, 2019

While there are many perspectives and publications on the “Hospital of the Future,” few, if any, provide a system perspective. Too often, when imagining the Health System of the Future, a hospital-centric model emerges. The challenge in this hospital-centric view is that it ignores most ...

Read More

What Clinical Teams Should Know About Changing Trial Logistics WHAT CLINICAL TEAMS SHOULD KNOW ABOUT CHANGING TRIAL LOGISTICS

whitepaper

Feb 20, 2019

When it comes to clinical supplies, the journey is every bit as important as the destination. And these days, the journey of clinical supplies to investigator sites is becoming costlier and more complex, much like the global trials for which the materials are bound. The price of failure is high. A s...

Read More

Pharma 2020: Challenging business models Which path will you take? PHARMA 2020: CHALLENGING BUSINESS MODELS WHICH PATH WILL YOU TAKE?

whitepaper

Feb 20, 2019

The pharmaceutical marketplace is undergoing huge changes, as we indicated in “Pharma 2020: The vision”, the White Paper PricewaterhouseCoopers* published in June 2007.1 These changes will have a major bearing on the kind of business models pharmaceutical companies need to employ. Most B...

Read More

Using flexible-content syndromic panels to help manage infectious disease USING FLEXIBLE-CONTENT SYNDROMIC PANELS TO HELP MANAGE INFECTIOUS DISEASE

whitepaper

Feb 18, 2019

Recently, rapid advancements have been made in molecular testing technology for infectious diseases. This white paper briefly reviews those advances and discusses the choices laboratory managers face in light of them. We focus on flexible-content syndromic panels for respiratory, gastrointestinal, a...

Read More

Measuring Volatile Organic Compounds (VOCs) in Pharmaceuticals MEASURING VOLATILE ORGANIC COMPOUNDS (VOCS) IN PHARMACEUTICALS

whitepaper

Feb 18, 2019

The monitoring of biotechnological fermentation processes, used for the production of modern biopharmaceutical drugs, is becoming ever more relevant for the promotion of economic production, particularly within the manufacturing sector. Up until now, biotechnical techniques have typically been monit...

Read More

The challenges of scaling up pharmaceutical manufacturing THE CHALLENGES OF SCALING UP PHARMACEUTICAL MANUFACTURING

whitepaper

Feb 18, 2019

Maintaining the integrity of a drug during a pharmaceutical manufacturing scale-up isn’t always an easy feat, but it’s essential for producers who wish to grow their operation while ensuring high standards and legal compliance.

Read More

Pharma R&D Annual Review 2019 PHARMA R&D ANNUAL REVIEW 2019

whitepaper

Feb 15, 2019

Pharma R&D Annual Review 2019 is based on the stats and data from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects, this whitepaper contains the whole nine yards.

Read More

Rising to Meet Healthcare Industry Challenges RISING TO MEET HEALTHCARE INDUSTRY CHALLENGES

whitepaper

Feb 13, 2019

Discover what strategies healthcare organizations are undertaking to address the top issues that face them: addressing cost pressures resulting from declining reimbursements and improving the patient experience. Learn about the steps necessary to address these issues and become an intelligent enterp...

Read More

Artificial Intelligence in Healthcare ARTIFICIAL INTELLIGENCE IN HEALTHCARE

whitepaper

Feb 12, 2019

Since the inception of electronic health record (EHR) systems, volumes of patient data have been collected, creating an atmosphere suitable for translating data into actionable intelligence. The growing field of artificial intelligence (AI) has created new technology that can tackle large data sets,...

Read More

Molecular Spectroscopy of Glues for Quality Control and Development MOLECULAR SPECTROSCOPY OF GLUES FOR QUALITY CONTROL AND DEVELOPMENT

whitepaper

Feb 12, 2019

Adhesives are indispensable in the automotive, aeronautic, and medical industries, among others. Modern adhesives are complex, and their quality requires an assessment of initial components as well as the final product. Molecular spectroscopy approaches, including FTIR and Raman, can be used to iden...

Read More

Detecting Pharmacy Fraud: Is Your Brand’s Co-Pay Program Protected? DETECTING PHARMACY FRAUD: IS YOUR BRAND’S CO-PAY PROGRAM PROTECTED?

whitepaper

Feb 12, 2019

The incidences of pharmacy fraud involving pharmaceutical manufacturers’ co-pay card programs are on the rise. In this white paper, TrialCard discusses the steps it has taken to expand its Pharmacy Fraud Monitoring service, which identifies fraud and greatly reduces the reimbursement funds tha...

Read More

Avoiding Hemolysis Blood Sample Collection Processing AVOIDING HEMOLYSIS BLOOD SAMPLE COLLECTION PROCESSING

whitepaper

Feb 11, 2019

Depending on your point of view, red blood cells, or erythrocytes, are throwaways and a nuisance, ruining a good blood specimen if the cells burst and contaminate the sample. On the other hand, erythrocytes have significant value in specific types of research, and if your objective is biobanking the...

Read More

Taking the TAKING THE 'HIGH' OUT OF PAIN

whitepaper

Feb 04, 2019

Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain. Initially, physicians were misinformed that addiction to these medications was highly unlikely in a clinical setting, causing a shift towards prescribing opioids as the drug ...

Read More

Achieving Competitive Advantage With Anatomy And Physiology ACHIEVING COMPETITIVE ADVANTAGE WITH ANATOMY AND PHYSIOLOGY

whitepaper

Feb 04, 2019

This whitepaper explores how best in class anatomy, physiology and clinical content, images and customised solutions enable organizations to achieve strong competitive advantage, drive credibility, productivity and differentiation. We will share ideas that you can consistently apply to your own orga...

Read More

Improve pipetting of Viscous Liquids in Pharmaceutical Formulations IMPROVE PIPETTING OF VISCOUS LIQUIDS IN PHARMACEUTICAL FORMULATIONS

whitepaper

Feb 01, 2019

Whilst commonly used air displacement pipettes are highly accurate for most liquid dispensing applications, the viscosity, volatility, surface tension and temperature of the solution can adversely affect their performance. In pharmaceutical formulations, frequently used liquids, like glycerol, are m...

Read More

Hitting a Biological Bullseye with Targeted Sequence Analysis HITTING A BIOLOGICAL BULLSEYE WITH TARGETED SEQUENCE ANALYSIS

whitepaper

Jan 31, 2019

Cellular heterogeneity plays a critical role in systems and pathologies, but many genomic analysis techniques derive their findings from multicellular samples, potentially burying key information from individual cells or rare subsets. Next-generation sequencing-based single-cell whole transcriptome ...

Read More

Polymers for Drug-Device Combination Products POLYMERS FOR DRUG-DEVICE COMBINATION PRODUCTS

whitepaper

Jan 28, 2019

A wide variety of polymer types are available to the DDCP developer,
and many are available on the market that meet the necessary
regulatory requirements. Careful consideration should be given to
the choice of vendor to ensure that quality and consistency are
met. The ava...

Read More

Use of Artificial Intelligence and Advanced Analytics in pharmaceuticals. USE OF ARTIFICIAL INTELLIGENCE AND ADVANCED ANALYTICS IN PHARMACEUTICALS.

whitepaper

Jan 25, 2019

Artificial intelligence helps pharma companies find patients for clinical trials. While AI can be used to make sense of clinical trials data, another use of artificial intelligence in the pharmaceutical industry is to find the patients to take them.

Read More

Evaluate Medical Device Design Robustness By Combining Statistical And Probabilistic Tools With Finite Element Analysis EVALUATE MEDICAL DEVICE DESIGN ROBUSTNESS BY COMBINING STATISTICAL AND PROBABILISTIC TOOLS WITH FINITE ELEMENT ANALYSIS

whitepaper

Jan 25, 2019

Finite Element Analysis (FEA) has been widely used to analyze the in vivo structural response of implantable medical devices and assess device performance, reliability and durability. In order to obtain a robust design, parameter variations and their influence on device performance need to be unders...

Read More

The Lifetime Value of Patient Loyalty THE LIFETIME VALUE OF PATIENT LOYALTY

whitepaper

Jan 21, 2019

Patient satisfaction is currently treated as one proxy for the quality of care a patient receives. Admittedly subjective, satisfaction survey scores are nonetheless put to all kinds of concrete purposes, from reimbursement to performance pay. While satisfaction scores undoubtedly help gauge the expe...

Read More

2019 National Drug & Alcohol IQ Challenge 2019 NATIONAL DRUG & ALCOHOL IQ CHALLENGE

whitepaper

Jan 18, 2019

ON DRUGS AND DRUG U. BY TAKING THE: 2019. National Drug. & Alcohol. IQ Challenge.

Read More

Toxin Neutralization Using Alternative Binding Proteins TOXIN NEUTRALIZATION USING ALTERNATIVE BINDING PROTEINS

whitepaper

Jan 17, 2019

Animal toxins present a major threat to human health worldwide, predominantly through snakebite envenomings, which are responsible for over 100,000 deaths each year. To date, the only available treatment against snakebite envenoming is plasma-derived antivenom. However, despite being key to limiting...

Read More

API CRYSTALLIZATION AND FORMULATION SOLUTIONS FOR TODAY’S DRUG DEVELOPMENT NEEDS API CRYSTALLIZATION AND FORMULATION SOLUTIONS FOR TODAY’S DRUG DEVELOPMENT NEEDS

whitepaper

Jan 15, 2019

Crystallization of active pharmaceutical ingredients (API) and related pre- and early formulation development play critical roles in successful drug development and manufacturing. The associated challenges can create significant roadblocks in the production of APIs and drug products as well as compl...

Read More

Growing Attention Being Paid To Pharma Company Rebates And Discounts GROWING ATTENTION BEING PAID TO PHARMA COMPANY REBATES AND DISCOUNTS

whitepaper

Jan 14, 2019

Drug company rebates and discounts have always been an opaque aspect of the US pharma industry. There is little transparency in how much drug companies pay in rebates and discounts. Indications are it is annually in the tens of billions of dollars for the industry and growing. Price concessions can ...

Read More

Secure sterile transfer in pharmaceutical production SECURE STERILE TRANSFER IN PHARMACEUTICAL PRODUCTION

whitepaper

Jan 14, 2019

Sterile transfer of components and other materials between sterile and non-sterile areas has always been a major concern in the pharmaceutical production industry. Previously, injectables and other medicinal products were produced in conventional clean rooms with insufficient protective barrier syst...

Read More

Challenges And Opportunities To Commercialize Orphan Drugs For Rare Diseases In The US CHALLENGES AND OPPORTUNITIES TO COMMERCIALIZE ORPHAN DRUGS FOR RARE DISEASES IN THE US

whitepaper

Jan 13, 2019

Orphan drugs (ODs) for rare diseases (RDs) present pharma companies with the opportunity to address a substantial unmet medical need, with approximately 7,000 RDs, and only about 5% having effective treatments. A large number of patients in the US are affected with these RDs (around 25-30 million pe...

Read More

GABAA Receptors Application Note GABAA RECEPTORS APPLICATION NOTE

whitepaper

Jan 11, 2019

GABAA receptors represent a large and complex family of ion channels that consist of at least 16 subunits (α1-6, β1-3, γ1-3, δ, ε, π, θ) and have been shown to be vital for the normal functioning of the brain. These ligand-gated chloride ion channels form pent...

Read More

Introduction to Machine Learning in Healthcare INTRODUCTION TO MACHINE LEARNING IN HEALTHCARE

whitepaper

Jan 10, 2019

15 minutes. That’s how long your doctor has to see you, assess your complaint, diagnose a solution and see you out the door hopefully on the pathway back to wellness. This isn’t much time when you consider the wealth of information that he or she has to consider. Your patient record, the...

Read More

Protecting Healthcare Software PROTECTING HEALTHCARE SOFTWARE

whitepaper

Jan 10, 2019

For decades medical devices have been standalone instruments that interacted only with the patient or medical provider. The advent of technological innovations including miniaturization, low power computation, and wireless technologies has created a new paradigm in the healthcare industry: the Inter...

Read More

An Intelligent Solution for Hydrophillic Interaction Liquid Chromatography Method Development AN INTELLIGENT SOLUTION FOR HYDROPHILLIC INTERACTION LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT

whitepaper

Jan 08, 2019

In this white paper, it will be demonstrated that the use of three HILIC phases, which provide very different and complementary selectivity to one another, is both practical and effective for HILIC method development. These selectivity differences can be exploited, together with mobile phase pH, to ...

Read More

Pharma outlook 2030: From evolution to revolution PHARMA OUTLOOK 2030: FROM EVOLUTION TO REVOLUTION

whitepaper

Jan 07, 2019

The pharmaceutical sector is at a crossroads. In a heavily disrupted marketplace, characterized by shifting payer attitudes and patient empowerment, neither incremental adjustments nor steady evolution are likely to halt the decline of the traditional pharmaceutical business model. This paper looks ...

Read More

Digital Twins in Healthcare: Enabling mass personalization of care delivery DIGITAL TWINS IN HEALTHCARE: ENABLING MASS PERSONALIZATION OF CARE DELIVERY

whitepaper

Jan 05, 2019

In this paper, you will learn how far we have come in generating massive amounts of patient data, but how unprepared we are to make use of it. A digital twin promises an outcome-driven approach to handling the data deluge arising from the patient’s interconnected biology, provider interactions...

Read More

MBA Pharmaceutical Management Application deadline MBA PHARMACEUTICAL MANAGEMENT APPLICATION DEADLINE

whitepaper

Jan 04, 2019

The dates are confirmed, the syllabus completed and the course directors are ready to welcome you to the only MBA carefully developed for pharmaceutical leaders: the MBA Pharmaceutical Management.

Read More

Integrated Biologics: Enabling high throughput drug discovery at Amgen INTEGRATED BIOLOGICS: ENABLING HIGH THROUGHPUT DRUG DISCOVERY AT AMGEN

whitepaper

Jan 04, 2019

Large molecule discovery and development is a complex series of interwoven cycles that span many teams within a research and development organization. By making a commitment to informatics, Amgen pioneered the shift to large molecules and was on the forefront of addressing the complexity of large mo...

Read More

Clinical Breakthroughs in Urological Cancers can be a Double-Edged Sword as Payers are Forced to Act CLINICAL BREAKTHROUGHS IN UROLOGICAL CANCERS CAN BE A DOUBLE-EDGED SWORD AS PAYERS ARE FORCED TO ACT

whitepaper

Jan 04, 2019

Checkpoint inhibitors in bladder cancer, combination regimens in renal cell carcinoma (RCC) and novel anti-androgens in early prostate cancer treatment lines have demonstrated patient benefit, increasing survival times and addressing major areas of unmet need. However, payers are concerned about the...

Read More

Container Closure Integrity Testing (CCIT) testing for the pharmaceutical industry CONTAINER CLOSURE INTEGRITY TESTING (CCIT) TESTING FOR THE PHARMACEUTICAL INDUSTRY

whitepaper

Jan 02, 2019

The quality and efficacy of drugs depends significantly on their proper packaging: Sterile products and moisture / oxygen sensitive drugs require excellent sealing throughout the shelf life of the product (up to a few years) in order to protect it from biological contamination and the ingress of wat...

Read More

Musculoskeletal Program Clinical Appropriateness Guidelines MUSCULOSKELETAL PROGRAM CLINICAL APPROPRIATENESS GUIDELINES

whitepaper

Jan 01, 2019

AIM’s Clinical Appropriateness Guidelines (hereinafter “AIM’s Clinical Appropriateness Guidelines” or the “Guidelines”) are designed to assist providers in making the most appropriate treatment decision for a specific clinical condition for an individual. As used ...

Read More

THE HEALTH AND TECH
TRENDS THAT WILL SHAPE
PHARMA MARKETING IN 2019 THE HEALTH AND TECH TRENDS THAT WILL SHAPE PHARMA MARKETING IN 2019

whitepaper

Dec 28, 2018

Intouch’s annual trends report highlights the healthcare and tech trends that will shape the year ahead. You can look back and see our predictions for 2018, 2017, and 2016. And if you do, you might think — wait! Some of these trends look familiar from previous years! If so — you&rs...

Read More

Measuring the Impact of Pharmacy Customer Loyalty on Health System Utilization and Readmission Rates MEASURING THE IMPACT OF PHARMACY CUSTOMER LOYALTY ON HEALTH SYSTEM UTILIZATION AND READMISSION RATES

whitepaper

Dec 27, 2018

Quantifying the direct and indirect value that a business unit delivers to its parent health system has traditionally been difficult. In this case study, we discuss the impact of pharmacy customer loyalty on the Fairview Health Services system, and we introduce a new, data-driven methodology for mea...

Read More

Cloud Computing in Pharmaceutical Research and Development CLOUD COMPUTING IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT

whitepaper

Dec 26, 2018

Cloud computing represents an IT service model which helps in the delivery of computing services, both hardware and software, to customers, on demand, over a network, which utilizes the internet. Thus, users only incur operating expenses associated with the time and length of usage, and are not requ...

Read More

Efficient Removal of Aggregates from Monoclonal Antibodies EFFICIENT REMOVAL OF AGGREGATES FROM MONOCLONAL ANTIBODIES

whitepaper

Dec 26, 2018

Monoclonal antibody (mAb) therapeutics have been widely used to treat various diseases, including cancer. Oftentimes, dimers and other high molecular weight aggregates are present in the mAb therapeutics, leading to reduced biological activity. Traditionally-used methods for aggregate removal rely h...

Read More

Next Generation Therapies: Innovative Drug Development Approaches for Rare Diseases NEXT GENERATION THERAPIES: INNOVATIVE DRUG DEVELOPMENT APPROACHES FOR RARE DISEASES

whitepaper

Dec 26, 2018

Scientific interest in rare disease drug discovery has been growing exponentially and the number of new therapies targeting rare and orphan diseases has doubled in the past 6 years. In this white paper, we have reviewed innovative approaches to develop successful therapies for rare diseases such as ...

Read More

HOW HEALTHCARE ORGANIZATIONS CAN REALIZE THE FULL POTENTIAL OF VDI WITH FLASH STORAGE HOW HEALTHCARE ORGANIZATIONS CAN REALIZE THE FULL POTENTIAL OF VDI WITH FLASH STORAGE

whitepaper

Dec 15, 2018

IT departments in large healthcare institutions face numerous challenges. They are expected to help implement new initiatives to improve patient care, oftentimes while having to support legacy applications that may have been cobbled together over many years. At the same time, they must follow ever-s...

Read More

2018 CONSUMER SURVEY ON DIGITAL HEALTH 2018 CONSUMER SURVEY ON DIGITAL HEALTH

whitepaper

Dec 14, 2018

Accenture commissioned a seven-country survey of 7,905 consumers aged 18+ to assess their attitudes toward healthcare technology, modernization and service innovation. The online survey included consumers across seven countries: Australia (1,031), England (1,043), Finland (848), Norway (768), Singap...

Read More

Considerations in Selecting a Population Health Management Solution CONSIDERATIONS IN SELECTING A POPULATION HEALTH MANAGEMENT SOLUTION

whitepaper

Dec 12, 2018

The most essential requirement to enable the ability to move forward with confidence on a population health strategy is a solid foundation of data and information that is connected, complete, accurate, and available in real time. The rapid digitization of health data of all types ensures that data w...

Read More

Rapid Sterility Testing of Filterable Samples RAPID STERILITY TESTING OF FILTERABLE SAMPLES

whitepaper

Dec 12, 2018

Sterility testing of final drug products is a mandatory release test for pharmaceutical companies and is critical to ensure patient safety. However, traditional methods such as membrane filtration require a minimum incubation time of 14 days. This long time to result in delays in product release and...

Read More

Enabling single-software multiple attribute methodology (MAM) for the assessment of biopharmaceutical product quality attributes ENABLING SINGLE-SOFTWARE MULTIPLE ATTRIBUTE METHODOLOGY (MAM) FOR THE ASSESSMENT OF BIOPHARMACEUTICAL PRODUCT QUALITY ATTRIBUTES

whitepaper

Dec 11, 2018

Development and production of biopharmaceuticals are complex. Even minor impurities, orchanges in attributes such as glycosylation or charge heterogeneity, can have a profound impact on the safety and = ef cacy of the nal product. Traditionally, multiple analytical techniques have been required to ...

Read More

Industry Trends Changing Sterile Filtration INDUSTRY TRENDS CHANGING STERILE FILTRATION

whitepaper

Dec 11, 2018

According to a recent report from the Tufts Center for the Study of Drug Development, the total price tag for bringing a new drug to market can be up to $2.7 billion.1 While development costs are high, keeping costs low during commercial production while delivering products that are safe for human u...

Read More

Multi-omics in Cancer Research MULTI-OMICS IN CANCER RESEARCH

whitepaper

Dec 10, 2018

The genome has given clinical researchers a powerful tool for understanding the biological foundations of many diseases, but it only tells part of the story. This ebook shows how different laboratories are employing mass spectrometry and other cutting-edge tools to collect richer datasets based on a...

Read More

Technical Documentation and Medical Device Regulation TECHNICAL DOCUMENTATION AND MEDICAL DEVICE REGULATION

whitepaper

Dec 05, 2018

Before placing a medical device on the European market, manufacturers need to produce technical documentation providing evidence of conformity with the relevant legislation. Technical documentation needs to be in compliance with the Medical Devices Directive (MDD) 93/42/EEC or the Active Implantable...

Read More

Microscan Gigabit Ethernet Cameras Provide Ampoule Inspection in the Pharmaceutical Industry MICROSCAN GIGABIT ETHERNET CAMERAS PROVIDE AMPOULE INSPECTION IN THE PHARMACEUTICAL INDUSTRY

whitepaper

Dec 05, 2018

Whether decoding Data Matrix symbols, reading text with Optical Character Recognition (OCR), or performing product inspection with machine vision, Industrielle Sensorsysteme Wichmann (ISW) GmbH has been meeting demanding applications with high-performance, turnkey automation solutions for over 20 ye...

Read More

Targeting breast cancer cell signaling molecules PI3K and Akt by phytochemicals Cannabidiol, Nimbin and Acetogenin TARGETING BREAST CANCER CELL SIGNALING MOLECULES PI3K AND AKT BY PHYTOCHEMICALS CANNABIDIOL, NIMBIN AND ACETOGENIN

whitepaper

Nov 30, 2018

The phosphatidylinositol 3-kinase (PI3K)/serine-threonine protein kinase Akt is a vital signaling cascade involved in cell survival, progression and thus causes various types of cancers. Various kinase inhibitors targeting PI3K/Akt have been extensively studied but promising results could not be obt...

Read More

Gene Therapy: A Paradigm Shift in Medicine GENE THERAPY: A PARADIGM SHIFT IN MEDICINE

whitepaper

Nov 30, 2018

Gene therapy, the modification of genetic information in living cells to address a mutated gene, has the ability to dramatically change the way diseases are treated, or even cured. First conceptualized in the early 1970s, the seminal paper on the subject was published in Science by Theodore Friedman...

Read More

One Plant ONE PLANT'S SECRET FOR ASSURING ASEPTIC CONTROL

whitepaper

Nov 29, 2018

Airflow visualization testing, conducted as part of a routine review program, can help assure that aseptic filling areas remain under a state of proper control. In fact, ISO standards recommend frequent airflow measurements. ISO standard 14644-2 requires “specifications for testing and monitor...

Read More

Selecting Filters To Address Your Bioburden Challenges SELECTING FILTERS TO ADDRESS YOUR BIOBURDEN CHALLENGES

whitepaper

Nov 28, 2018

Biologics development and manufacturing is inherently complex and challenging. Compounding this is the added pressure to be first to market in a highly competitive healthcare landscape, where delays can put the success of a product and company at risk. The implication for process development enginee...

Read More

Analysis of Pharmaceutical Raw Materials Through Packaging Using an FT-NIR Fiber Optic Probe ANALYSIS OF PHARMACEUTICAL RAW MATERIALS THROUGH PACKAGING USING AN FT-NIR FIBER OPTIC PROBE

whitepaper

Nov 28, 2018

The analysis of all incoming pharmaceutical raw materials is key part of 21CFR compliance.  It is therefore important to have a high-throughput method by which raw materials may be analyzed, while also preventing sample exposure. This application note explores the analysis and identification of...

Read More

Digital Pathology in Accelerating Drug Development DIGITAL PATHOLOGY IN ACCELERATING DRUG DEVELOPMENT

whitepaper

Nov 26, 2018

Tissue pathology is at the core of various aspects of the pharmaceutic pipeline. Digital pathology is a technology that converts glass microscope slides with tissue samples into whole slide digital images, which can be used to identify, quantify, and document key characteristics of tissue samples. T...

Read More

Current Therapeutic Targets for Alzheimer’s Disease CURRENT THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE

whitepaper

Nov 25, 2018

Alzheimer’s disease (AD) is one of the most common multifactorial diseases, including a range of abnormal cellular/molecular processes occurring in different regions of the brain. This disease is considered to be a major contributor to dementia in elderly people. The pathophysiology involves t...

Read More

Transforming health services delivery towards people-centered health systems TRANSFORMING HEALTH SERVICES DELIVERY TOWARDS PEOPLE-CENTERED HEALTH SYSTEMS

whitepaper

Nov 22, 2018

The briefing note at hand has been prepared to annotate with further conceptual clarity the structure and organization of the Framework for Action, with the objective of specifying the following: its strategic vision according to the determinants of people-centered health services; how needed transf...

Read More

What Pharma Should Do About Artificial Intelligence (AI) WHAT PHARMA SHOULD DO ABOUT ARTIFICIAL INTELLIGENCE (AI)

whitepaper

Nov 22, 2018

AI has the potential to provide huge benefits to the pharmaceutical industry, from improving R&D productivity through to more effective sales representative deployment and better supply chain management. Adoption of AI is lagging other sectors, with initial forays mainly being led by big pharma ...

Read More

Authorized representatives under the MDR AUTHORIZED REPRESENTATIVES UNDER THE MDR

whitepaper

Nov 21, 2018

The EU Medical Devices Regulation 2017/745 (MDR) has significantly increased the burden of compliance and potential legal liability exposure for economic operators, including EU authorized representatives (ARs) of manufacturers established outside of the European Economic Area (EEA), Switzerland and...

Read More

Top health industry issues of 2019 TOP HEALTH INDUSTRY ISSUES OF 2019

whitepaper

Nov 19, 2018

The US health industry has often lagged other industries—think tech, retail, hospitality when it comes to modernizing. Once thought to operate outside the greater US economy, the industry with its byzantine payment system, complicated regulatory barriers, and reliance on face-to-face interacti...

Read More

Lentivirus 101: Simple Gene Delivery LENTIVIRUS 101: SIMPLE GENE DELIVERY

whitepaper

Nov 18, 2018

Lentiviruses are single-stranded RNA viruses and the second major subgroup of the retroviruses. Lentiviruses are powerful tools in molecular biology. They have long incubation periods and are capable of delivering relatively large loads of genetic information into the DNA of a broad range of cells w...

Read More

National Service Framework for Diabetes NATIONAL SERVICE FRAMEWORK FOR DIABETES

whitepaper

Nov 17, 2018

Less than a hundred years ago diabetes was a death warrant. The discovery of insulin in The 1920s was a major breakthrough. Since then, thanks to the dedicated work of scientists, researchers, doctors, and nurses in this country and abroad, there have been huge strides forward in our knowledge of di...

Read More

Technology innovation will help prepare drug discovery for smart screening era TECHNOLOGY INNOVATION WILL HELP PREPARE DRUG DISCOVERY FOR SMART SCREENING ERA

whitepaper

Nov 16, 2018

Drug discovery is undergoing a transformation powered by advances that provide more knowledge from biological assays, allow for screening orders of magnitude more molecules and enable smarter selection of compounds. We are on the cusp of having previously unimaginable amounts of information about ea...

Read More

Non-Destructive Hardness Testing NON-DESTRUCTIVE HARDNESS TESTING

whitepaper

Nov 15, 2018

Tablet hardness testing plays an important role in pharmaceutical product development and quality control. In the race to streamline tablet hardness analysis, Advantest combines speed, simplicity and increased the precision with innovative and non-destructive terahertz (THz) metrology.

Read More

Metabolomics in Cancer Research METABOLOMICS IN CANCER RESEARCH

whitepaper

Nov 14, 2018

Metabolomics is an emerging field of “omics” concerned with measuring and interpreting the metabolic state (i.e. metabolome) and is an essential technology for defining the key functional attributes of tumors or cancer cells.

Read More

Innovations in Cancer Screening INNOVATIONS IN CANCER SCREENING

whitepaper

Nov 13, 2018

How advances in imaging technology and the use of artificial intelligence and analytics are improving the accuracy and cost of medical imaging for early cancer diagnosis, and increasing confidence in vital preventive screening programs.

Read More

A LC-MS Approach to Screen Drugs in Drug Consumption Rooms A LC-MS APPROACH TO SCREEN DRUGS IN DRUG CONSUMPTION ROOMS

whitepaper

Nov 13, 2018

In this study, the Toxtyper is used for drug screening in drug consumption rooms which are seen as an important element to minimize drug-related health problems (e.g. infection risk) and promote contact of drug users with employees of drug help programs.

Read More

WHAT HEALTHCARE ORGANIZATIONS SHOULD KNOW ABOUT THE GDPR WHAT HEALTHCARE ORGANIZATIONS SHOULD KNOW ABOUT THE GDPR

whitepaper

Nov 12, 2018

Data protection regulations define how an individual’s personal information can be used by organizations, businesses, and government. These regulations also contain safeguards that seek to ensure healthcare data is not susceptible to attack, misuse or misappropriation. As most know, misusing a...

Read More

The Accenture Digital Health Technology Vision 2017 THE ACCENTURE DIGITAL HEALTH TECHNOLOGY VISION 2017

whitepaper

Nov 12, 2018

Technology for People shows the way to an exciting future where healthcare technology is designed by humans, for humans, to create positive change that can transform healthcare organizations and society. Digital breakthroughs are enabling healthcare enterprises to improve labor productivity, cl...

Read More

Be Immortal BE IMMORTAL

whitepaper

Nov 12, 2018

Immortality has long been treated as a work of fiction - a trait only possessed by mythological Gods and divine creatures. Is there an afterlife or life after death? Each religion or system of belief had its own way to deal with such questions. Certain scientists and philosophers, writers have theor...

Read More

Emerging Trends and Technology-Clinical Trials Data as RDF EMERGING TRENDS AND TECHNOLOGY-CLINICAL TRIALS DATA AS RDF

whitepaper

Nov 12, 2018

This white paper outlines the philosophy, methods, and deliverables for the PhUSE Computational Sciences Symposium Emerging Trends and Technology working group project “Clinical Trials Data as RDF.” The project was formed to investigate the feasibility of using Linked Data as a future-pr...

Read More

How to build and sustain a ‘capable’ healthcare system HOW TO BUILD AND SUSTAIN A ‘CAPABLE’ HEALTHCARE SYSTEM

whitepaper

Nov 10, 2018

What matters most when building and sustaining a healthcare organization? What are the precise levers to pull to promote physician well being, financial success, and better outcomes at lower cost? To answer these questions, Athena health launched an ongoing research project in 2016. Now in its secon...

Read More

Analysis and Compliance in Pharmaceuticals ANALYSIS AND COMPLIANCE IN PHARMACEUTICALS

whitepaper

Nov 10, 2018

Pharmaceuticals play a prominent role worldwide. This widespread presence is met with regulatory requirements at each phase of pharmaceutical development and manufacturing—from inspection of raw materials to quality control of final products. Consistently producing pharmaceuticals that both co...

Read More

2017 Clinical Trials Roundup The Evolution Continues 2017 CLINICAL TRIALS ROUNDUP THE EVOLUTION CONTINUES

whitepaper

Nov 08, 2018

The landscape of clinical trials continues to evolve over time as scientific breakthroughs and technological innovations emerge, which continue to be tracked by assessing recently initiated trials through Trialtrove’s annual Clinical Trials Roundup.

Read More

Reforming America’s Healthcare System Through Choice and Competition REFORMING AMERICA’S HEALTHCARE SYSTEM THROUGH CHOICE AND COMPETITION

whitepaper

Nov 08, 2018

On October 12, 2017, through Executive Order 13813, you directed the Administration, to the extent consistent with the law, to facilitate the development and operation of a health care system that provides high-quality care at affordable prices for the American people by promoting choice and competi...

Read More

BROADENING THE DEFINITION OF TOLERABILITY IN CANCER CLINICAL TRIALS TO BETTER MEASURE THE PATIENT EXPERIENCE BROADENING THE DEFINITION OF TOLERABILITY IN CANCER CLINICAL TRIALS TO BETTER MEASURE THE PATIENT EXPERIENCE

whitepaper

Nov 07, 2018

Robust safety and tolerability data are essential in cancer therapeutic studies, and some trials are specifically designed with a key objective of demonstrating improved safety and tolerability. The development of a clinical trial framework and data elements to demonstrate comparative safety and tol...

Read More

A Hearing Health Benefit A HEARING HEALTH BENEFIT

whitepaper

Nov 06, 2018

Across the country, hearing health is becoming a hot topic of conversation and it’s grabbing the attention of the organizations that deliver health care benefits to millions of Americans. Driving this phenomenon are several wide-ranging factors as shown below.

Read More

A Digital Health Intelligence white paper supported by Samsung A DIGITAL HEALTH INTELLIGENCE WHITE PAPER SUPPORTED BY SAMSUNG

whitepaper

Nov 05, 2018

This white paper represents a key piece of research into the potential benefits of mobile working in healthcare and considers the obstacles that will have to be surmounted along the way. Given our research was conducted in the aftermath of last May’s WannaCry attack, it will come as little sur...

Read More

Depression New Insights Shifting the Treatment Paradigm Whitepaper DEPRESSION NEW INSIGHTS SHIFTING THE TREATMENT PARADIGM WHITEPAPER

whitepaper

Nov 05, 2018

Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are in Depression: New Insights Shifting the Treatment Paradigm.

Read More

Unlocking digital health: Opportunities for the mobile value chain UNLOCKING DIGITAL HEALTH: OPPORTUNITIES FOR THE MOBILE VALUE CHAIN

whitepaper

Nov 02, 2018

Mobile value chain revenues in the US grew 10 percent per annum from 2009 to 2014, and profits rose by as much as 15 percent. The year 2015 is expected to see 3 percent growth in revenues and 6 percent growth in profits.

Read More

STATE TELEHEALTH LAWS & REIMBURSEMENT POLICIES STATE TELEHEALTH LAWS & REIMBURSEMENT POLICIES

whitepaper

Nov 02, 2018

The Center for Connected Health Policy’s (CCHP) Fall 2018 release of its report on “State Telehealth Laws and Reimbursement Policies” offers policymakers, health advocates, and other interested health care professionals a freshly redesigned summary guide of telehealth-related polic...

Read More

Utilizing External Collaboration To Accelerate Vaccine Development UTILIZING EXTERNAL COLLABORATION TO ACCELERATE VACCINE DEVELOPMENT

whitepaper

Nov 02, 2018

As the pharmaceutical industry continues to look for new and innovative ways to treat disease, some companies are putting more focus on how to prevent them. Vaccine development, while a long and complex process, has the potential to save millions of lives globally, especially in low-income countries...

Read More

Transforming Healthcare IT with Enterprise Cloud TRANSFORMING HEALTHCARE IT WITH ENTERPRISE CLOUD

whitepaper

Nov 02, 2018

A Nutanix enterprise cloud reduces the cost and complexity of IT infrastructure for healthcare while improving scaling, availability, and data protection. Conventional infrastructure is no longer able to address healthcare challenges, such as regulatory hurdles, resource constraints, highly mobile w...

Read More

Raman Spectroscopy Tools Techniques Applications RAMAN SPECTROSCOPY TOOLS TECHNIQUES APPLICATIONS

whitepaper

Oct 30, 2018

Raman spectroscopy has taken large strides in recent years as more Raman vendors have developed handheld Raman units capable of carrying out raw material identification or verification. Raman spectroscopy is used as a fingerprinting tool to capture the unique Raman spectrum of each raw material. The...

Read More

Follow-on drugs: Circumventing the customary patent cliffs in Big Pharma FOLLOW-ON DRUGS: CIRCUMVENTING THE CUSTOMARY PATENT CLIFFS IN BIG PHARMA

whitepaper

Oct 30, 2018

Follow-on drugs, also referred to as ‘next-generation drugs’, are ‘an established practice’ among drug innovators. They are one of the most effective R&D strategies implemented by drug innovators, and can be considered a cannibalization or switching strategy. In a nutshel...

Read More

Methods for deformulating drugs METHODS FOR DEFORMULATING DRUGS

whitepaper

Oct 25, 2018

The FDA has a number of regulatory routes through which a company can seek approval for a generic drug. The most notable is the Abbreviated New Drug Application (ANDA) route whereby a generic company develops an exact copy of the innovator product and can use the safety and efficacy data from the in...

Read More

Pharmaceutical Challenges Aided by a Laboratory Powder X-ray Diffraction (PXRD) System PHARMACEUTICAL CHALLENGES AIDED BY A LABORATORY POWDER X-RAY DIFFRACTION (PXRD) SYSTEM

whitepaper

Oct 22, 2018

This white paper explores a number of ways that today’s modern, laboratory-based  PXRD instrumentation and advanced software can greatly assist pharmaceutical scientists in their quest to develop high quality, stable products and accelerate their speed to market. All applications describe...

Read More

Hospital Pharmacies Offer an Untapped Source of Powerful Cost Savings HOSPITAL PHARMACIES OFFER AN UNTAPPED SOURCE OF POWERFUL COST SAVINGS

whitepaper

Oct 19, 2018

Facing increasing margin pressures—and having already implemented many proven cost reduction and revenue-increasing measures—hospitals and health systems have to find new ways of reducing their costs without compromising quality or patient safety. By drawing on the expertise of their pha...

Read More

Trump Administration Issues Drug Price Transparency Proposed Rule TRUMP ADMINISTRATION ISSUES DRUG PRICE TRANSPARENCY PROPOSED RULE

whitepaper

Oct 19, 2018

Although previous regulation of prescription drug advertising has come from the U.S. Food and Drug Administration (FDA), this proposal comes from the Centers for Medicare & Medicaid Services (CMS).

Read More

2017 Completed Trials 2017 COMPLETED TRIALS

whitepaper

Oct 18, 2018

As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this an...

Read More

Benefits of hard X-radiation BENEFITS OF HARD X-RADIATION

whitepaper

Oct 15, 2018

This white paper outlines the main benefits of using hard radiation for material analysis studies. X-ray powder diffractometers are generally equipped with X-ray sources using Cu anodes. For specific applications, however, switching to shorter wavelength, ‘harder’ radiation, like obtaine...

Read More

Developing and maintaining a quality management system for IVDs DEVELOPING AND MAINTAINING A QUALITY MANAGEMENT SYSTEM FOR IVDS

whitepaper

Oct 12, 2018

There are many different requirements with which in vitro diagnostic manufacturers must comply in order to place the product on the market. At the core of most of these requirements is a fundamental need to have a good quality management system (QMS) in place. This is certainly not a new requirement...

Read More

Pharma Partnering Trends Revealed Whitepaper PHARMA PARTNERING TRENDS REVEALED WHITEPAPER

whitepaper

Oct 12, 2018

Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships and is now available for you to download &ndash...

Read More

Driving Sales Behavior With Non-Cash Rewards DRIVING SALES BEHAVIOR WITH NON-CASH REWARDS

whitepaper

Oct 03, 2018

In the end, you need to be rewarding your sales reps with more than just money if you want to keep them motivated and if you want your sales compensation plan to deliver on its promises.

Read More

Change the sales rep experience, improve the customer experience CHANGE THE SALES REP EXPERIENCE, IMPROVE THE CUSTOMER EXPERIENCE

whitepaper

Oct 03, 2018

The first CRM launch truly changed the way sales were managed. We went from tracking customers on spreadsheets (and even in rolodexes) to tracking them and their attendant opportunities with software. It wasn’t long before reps started to feel the purpose of a CRM was more about preserving the...

Read More

Pipeline Management and Forecasting Are Key to Improving the Sales Experience PIPELINE MANAGEMENT AND FORECASTING ARE KEY TO IMPROVING THE SALES EXPERIENCE

whitepaper

Oct 03, 2018

Let’s explore some of the current processes around pipeline management and forecasting and how they can be improved.

Read More

Efficient Cleaning-In-Place Methods For Protein-Based Antibody Affinity Chromatography Resins EFFICIENT CLEANING-IN-PLACE METHODS FOR PROTEIN-BASED ANTIBODY AFFINITY CHROMATOGRAPHY RESINS

whitepaper

Oct 02, 2018

Chromatography resins used for the production of biopharmaceuticals need to be cleaned efficiently to ensure the safety and efficacy of the bioproduct. Impurities that are not removed can build up on the chromatography column and start to leach into the process material in subsequent cycles. Efficie...

Read More

Cybersecurity in the Age of Medical Devices CYBERSECURITY IN THE AGE OF MEDICAL DEVICES

whitepaper

Sep 28, 2018

Countless studies and articles have confirmed that connected medical devices from implantable products like pacemakers to diagnostic devices such as CT scanners and more are indeed vulnerable to malicious exploitation. This paper offers both technical and nontechnical solutions to help prevent and m...

Read More

The Evolution of Antibody-Drug Manufacturing THE EVOLUTION OF ANTIBODY-DRUG MANUFACTURING

whitepaper

Sep 27, 2018

Even before the 1980s, the notion of attaching a cytotoxic agent to a tumorspecific antibody captured the collective imagination of the international drug development community. Were antibodydrug conjugates (ADCs) the magic bullets everyone was looking for that could, among other things, cure cancer...

Read More

Drug Substance Solid State Characterization DRUG SUBSTANCE SOLID STATE CHARACTERIZATION

whitepaper

Sep 27, 2018

A thorough knowledge of an active pharmaceutical ingredient’s (API) solid state behavior is essential for reliable drug product manufacturing, patent protection, and formulation viability. This article discusses various aspects of the API in the solid state which can impact pharmaceutical prod...

Read More

Advancing human genetics research with nanopore sequencing ADVANCING HUMAN GENETICS RESEARCH WITH NANOPORE SEQUENCING

whitepaper

Sep 26, 2018

High-throughput sequencing technologies have revolutionized the field of human genetics, allowing researchers to more easily investigate and understand biological processes and their impact. Using these technologies, researchers can analyze entire genomes or specific targeted regions of interest, wi...

Read More

Blockchain Adoption in Pharma Supply BLOCKCHAIN ADOPTION IN PHARMA SUPPLY

whitepaper

Sep 24, 2018

Experts have asserted that despite recent developments, pharmaceutical supply chains are still far from reaching their full technological potential. Blockchain holds significant promise to advance the digital strength of medicine supply.

Read More

In Search of a Disease-Modifying Agent for Parkinson’s Disease IN SEARCH OF A DISEASE-MODIFYING AGENT FOR PARKINSON’S DISEASE

whitepaper

Sep 21, 2018

In this white paper, we review a successful small molecule drug discovery project conducted by a team of scientists from Genentech and Charles River that spanned hit identification and lead optimization of a highly potent LRRK2 inhibitor.

Read More

Medical devices 2030 MEDICAL DEVICES 2030

whitepaper

Sep 21, 2018

While the outlook for medical device companies appears positive, unsustainable health care costs and new competitive forces threaten to alter the future industry landscape. If today’s manufacturers fail to stake their claim in the evolving value chain, they risk being caught in the middle and ...

Read More

Top 4 Network Security Challenges in Healthcare TOP 4 NETWORK SECURITY CHALLENGES IN HEALTHCARE

whitepaper

Sep 19, 2018

CIO’s and IT professionals in healthcare organizations are tasked with achieving a balance between the demand for universal access to information and the need to ensure security. In particular, four critical challenges these organizations face in terms of striking this balance include the foll...

Read More

Understanding And Defining Laboratory Capacity In Biopharma UNDERSTANDING AND DEFINING LABORATORY CAPACITY IN BIOPHARMA

whitepaper

Sep 18, 2018

Has anyone asked you, "What is your laboratory capacity?" In the scientific world of planning laboratories, defining capacity is not so straightforward. This makes answering the question challenging unless you have a method in place. The reality is, you have options for measuring your labo...

Read More

Enabling Genomics-Guided Precision Medicine ENABLING GENOMICS-GUIDED PRECISION MEDICINE

whitepaper

Sep 18, 2018

The era of precision medicine has arrived, and with it, a tidal wave of data from disparate sources, including electronic health records (EHRs), lab systems, pathology, and genomics. By integrating data from all available sources and analyzing it in smart ways, clinicians can finally get a complete ...

Read More

THE DENTIST’S GUIDE TO PATIENT FINANCING THE DENTIST’S GUIDE TO PATIENT FINANCING

whitepaper

Sep 17, 2018

If you’ve ever bought a car, remodeled a room in your home, or shopping for a high-end TV, chances are the business you purchased from offered you a financing plan. The appeal of financing is simple: it helps people buy things they normally couldn’t afford. Financing is a convenient solu...

Read More

Blood Conservation With A Patient Dedicated Arterial Blood Gas Analyser BLOOD CONSERVATION WITH A PATIENT DEDICATED ARTERIAL BLOOD GAS ANALYSER

whitepaper

Sep 16, 2018

Anemia is a frequent complication of critical care, with up to 90% of ICU (Intensive Care Unit) patients being anemic by their third day in the ICU1. Anemia is associated with poor patient outcomes, especially amongst those patients with cardiovascular disease2345. The treatments of choice for anemi...

Read More

Disease Diagnosis in Smart Healthcare: Innovation,
Technologies and Applications DISEASE DIAGNOSIS IN SMART HEALTHCARE: INNOVATION, TECHNOLOGIES AND APPLICATIONS

whitepaper

Sep 16, 2018

To promote sustainable development, the smart city implies a global vision that merges artificial intelligence, big data, decision making, information and communication technology (ICT), and the internet-of-things (IoT). The aging issue is an aspect that researchers, companies, and the governme...

Read More

The European Medical Devices Regulations THE EUROPEAN MEDICAL DEVICES REGULATIONS

whitepaper

Sep 15, 2018

The publication of the stable text of the European Union (EU) Medical Devices Regulation (MDR), and the In Vitro Diagnostic Medical Devices Regulation (IVDR), in June 2016 documented political agreement between the three EU Institutions – the Commission, the Parliament, and the Council –...

Read More

The Future of The Healthcare Market Reaction Data - 2018 THE FUTURE OF THE HEALTHCARE MARKET REACTION DATA - 2018

whitepaper

Sep 15, 2018

The healthcare IT landscape continues to change. One minute you’re convinced the world is round and then a series of new technological advancements, entrants into the market, and mergers and acquisitions give it the appearance of being flat. Then news breaks and it becomes a Rubik’s cube...

Read More

Rapid and affordable antimicrobial resistance profiling of tuberculosis samples RAPID AND AFFORDABLE ANTIMICROBIAL RESISTANCE PROFILING OF TUBERCULOSIS SAMPLES

whitepaper

Sep 10, 2018

With over 10 million new cases worldwide each year and approximately 1.7 million deaths, tuberculosis (TB) is one of the leading global threats to human health. While disease detection and control methods have yielded a steady decline in the number of deaths attributable to TB, the emergence of mult...

Read More

Pharma Partnering Trends Revealed: 2018 Edition PHARMA PARTNERING TRENDS REVEALED: 2018 EDITION

whitepaper

Sep 09, 2018

When you experience the choreography of tens of thousands of face-to-face meetings at BIO-Europe®, you know for certain that partnering is still the deal in the biotech industry. From nearly 1,000 partnering booths, executives from across the industry value chain pitch assets, exchange ideas, an...

Read More

Enabling Data Integrity from Drug Discovery through Manufacturing ENABLING DATA INTEGRITY FROM DRUG DISCOVERY THROUGH MANUFACTURING

whitepaper

Sep 06, 2018

When discussing the success of a drug therapy, a common topic amongst biopharmaceutical companies is data quality and data integrity; what the challenges are and what the key elements are to ensuring that the latest discovery is patentable, does not result in re-conducting critical research or devel...

Read More

Biosimilars: Regulatory Trends And Manufacturing Considerations BIOSIMILARS: REGULATORY TRENDS AND MANUFACTURING CONSIDERATIONS

whitepaper

Aug 28, 2018

Unlike well-defined chemical medicinal products and their generic counterparts, biologics and their biosimilar counterparts employ sophisticated bioprocessing technologies that utilize living systems for their manufacture. Because these complex heterogeneous protein molecules are produced in living ...

Read More

FHIR FINALLY BRINGS THE INTERNET TO BEAR ON HEALTHCARE’S BIG DATA FHIR FINALLY BRINGS THE INTERNET TO BEAR ON HEALTHCARE’S BIG DATA

whitepaper

Aug 27, 2018

Pervading every facet of daily life, the information superhighway that society has come to know and love – and occasionally loathe – has enabled a level of communication, collaboration, insight, and analysis that has rendered the current generation of smartphone-addicted kindergarten cod...

Read More

HPLC vs UHPLC HPLC VS UHPLC

whitepaper

Aug 24, 2018

Liquid chromatography is a technique of key importance for many areas of chemical analysis and one that has evolved with the progression of technology and instrumentation over time. Here we highlight some of the key similarities and differences between high-performance liquid chromatography (HPLC) a...

Read More

Contact Centers in Healthcare: A Report for Hospital Leaders CONTACT CENTERS IN HEALTHCARE: A REPORT FOR HOSPITAL LEADERS

whitepaper

Aug 22, 2018

Fifty-one percent of national survey respondents say they’ve had a contact center strategy in place 3 – 5 years, and 48 percent call their strategy an enterprise transformation initiative. Can maximizing this resource take your hospital into the future? See what your peers are saying abo...

Read More

Utilizing a Protocol Cost Saving Analysis to Reduce Drug Development Costs UTILIZING A PROTOCOL COST SAVING ANALYSIS TO REDUCE DRUG DEVELOPMENT COSTS

whitepaper

Aug 21, 2018

Over the years, studies have been conducted to ascertain the cost of research and development (“R&D”) required to bring a new drug to market. Experts disagree on the exact amount, but the consensus is that the figure is in the hundreds of millions to over a billion dollars. Pharmaceu...

Read More

4 Top Trends in Healthcare Data Analysis to Adopt Today 4 TOP TRENDS IN HEALTHCARE DATA ANALYSIS TO ADOPT TODAY

whitepaper

Aug 18, 2018

The healthcare industry has never been more focused on data its promise and its pitfalls as it is today. From slashing health care spending to detecting fraud or coordinating care across multiple providers improved the use of healthcare data has been held up as a “silver bullet” to slay ...

Read More

THE KEY TO IMPROVING THE MODERN PATIENT EXPERIENCE THE KEY TO IMPROVING THE MODERN PATIENT EXPERIENCE

whitepaper

Aug 15, 2018

The patient experience is the sum of all the interactions had with a healthcare organization. Therefore, the experience itself hasn't confined to the walls of a hospital or the examination rooms of an outpatient clinic the experience starts anywhere and anytime the patient first encounters the h...

Read More

Understanding Cloud Security in Healthcare UNDERSTANDING CLOUD SECURITY IN HEALTHCARE

whitepaper

Aug 12, 2018

Cloud computing is having a profound impact on healthcare. The healthcare cloud computing market is projected to almost triple between 2015 and 2020 to $9.48 billion.1 In the same time period, the Internet of Things (IoT) the number of devices connected to the Internet is projected to double to 40.9...

Read More

A Look at How a New B-27 Plus Formulation Improves Primary Neuron Survival and Neural Network Activity A LOOK AT HOW A NEW B-27 PLUS FORMULATION IMPROVES PRIMARY NEURON SURVIVAL AND NEURAL NETWORK ACTIVITY

whitepaper

Aug 10, 2018

Want to improve the reliability of your neuronal cell culture experiments by increasing the survival of the neurons? This white paper shows how the B-27 Plus Neuronal Culture System increases neuron survival and improves maturation and neural network activity.

Read More

Adaptation and conservation insights from the koala genome ADAPTATION AND CONSERVATION INSIGHTS FROM THE KOALA GENOME

whitepaper

Aug 08, 2018

The koala, the only extant species of the marsupial family Phascolarctidae, is classified as ‘vulnerable’ due to habitat loss and widespread disease. We sequenced the koala genome, producing a complete and contiguous marsupial reference genome, including centromeres. We reveal that the k...

Read More

Transitional Care Management: Connecting to Care TRANSITIONAL CARE MANAGEMENT: CONNECTING TO CARE

whitepaper

Aug 08, 2018

Transitional care encompasses a broad range of services and environments designed to promote the safe and timely passage of patients between levels of health care, across care settings, and among various providers. Care settings can include a range of points of care such as hospitals, long-term care...

Read More

THE GENETIC BLOCKCHAIN ECOSYSTEM THE GENETIC BLOCKCHAIN ECOSYSTEM

whitepaper

Aug 08, 2018

DNAtix intends to create a future ecosystem for Genetics where consumers, researchers, laboratories, and clinics operate making Genetics more accessible, transparent and anonymous. DNAtix intends to offer cutting-edge Genetics and Blockchain services which intend to be anonymous and encrypted and in...

Read More

PCR: Amplified to the End Point PCR: AMPLIFIED TO THE END POINT

whitepaper

Aug 08, 2018

30 years ago, polymerase chain reaction (PCR) burst onto the scene and steadily became one of the most common procedures in the lab. Advanced technologies have made it possible to achieve more accurate copies in a fraction of the time, no matter which of the several PCR-based methods you use. PCR is...

Read More

Overview of a scale-up of a cell-based influenza virus production process using single-use bioprocessing equipment OVERVIEW OF A SCALE-UP OF A CELL-BASED INFLUENZA VIRUS PRODUCTION PROCESS USING SINGLE-USE BIOPROCESSING EQUIPMENT

whitepaper

Aug 03, 2018

The aim of this white paper is to demonstrate how GE Healthcare Life Sciences single-use products can be applied in the field of vaccine manufacturing. The white paper includes a brief discussion on modern vaccine processes, followed by a case study showing the scale-up of upstream and downstream pr...

Read More

Neuromation NEUROMATION

whitepaper

Jul 30, 2018

Artificial Intelligence (AI) is seeing another spring and becoming a ubiquitous part of society. Researchers and engineers have made important steps towards solving practical problems in machine learning, particularly in such applications as vision, speech, machine translation, and decision making.

Read More

How Technology is Revealing the Big Picture in Pharma HOW TECHNOLOGY IS REVEALING THE BIG PICTURE IN PHARMA

whitepaper

Jul 24, 2018

The collection and analysis of data generated outside of restricted clinical trials are now critical to pharma companies. Data gathered in the routine delivery of healthcare can be mined to uncover insights into treatment efficacies and outcomes in the real world. Such insights, known as real-world ...

Read More

Incentive Compensation Management: Build Versus Buy INCENTIVE COMPENSATION MANAGEMENT: BUILD VERSUS BUY

whitepaper

Jul 23, 2018

Custom ICM solutions are built for you, not auditors, so they typically don’t offer visibility into actions performed over time. Auditors may lack confidence in your homegrown system, especially if they find errors or omissions. In fact, audit risk from errors and overpayments is often the mos...

Read More

The Three “S’s” of a Great Incentive Compensation Management System THE THREE “S’S” OF A GREAT INCENTIVE COMPENSATION MANAGEMENT SYSTEM

whitepaper

Jul 23, 2018

It all ties together. You want your sales reps to behave a certain way and close a certain amount of deals in specific verticals that match your company’s 3- and/or 5-year vision, but the systems you currently have in place to drive this behavior are not working for any number of reasons. Most...

Read More

Why Enterprise CPQ Implementations Fail WHY ENTERPRISE CPQ IMPLEMENTATIONS FAIL

whitepaper

Jul 23, 2018

You’ve reached a certain point in the evolution of your company and you know it’s time to invest in a CPQ system. But buyer beware: There’s a certain misconception around CPQ systems as being plug-in devices or turnkey-ready overlays of your existing infrastructure, or a simple app...

Read More

Moving Away from Spreadsheets: How to Know When It’s Time MOVING AWAY FROM SPREADSHEETS: HOW TO KNOW WHEN IT’S TIME

whitepaper

Jul 23, 2018

The spreadsheet conundrum... Joe Smith, sales director for Great Start-Up Number 5 Billion and Thirty-One, puts on a blindfold and reaches out blindly for something, ANYTHING, to help him organize his team’s deals and commissions. He’s hopeful. He’s waiting. He knows he’ll co...

Read More

Detection of immune checkpoint markers in peripheral blood mononuclear cell lysates with AlphaLISA DETECTION OF IMMUNE CHECKPOINT MARKERS IN PERIPHERAL BLOOD MONONUCLEAR CELL LYSATES WITH ALPHALISA

whitepaper

Jul 17, 2018

Quickly and easily quantitate immune checkpoint markers using a fraction of the sample volume required by traditional ELISA. In this technical note, we show how AlphaLISA can be used to detect and quantify additional immune checkpoint molecules within the PBMC population with and without activation ...

Read More

Planning for implementation of the European Union Medical Devices Regulations – Are you prepared? PLANNING FOR IMPLEMENTATION OF THE EUROPEAN UNION MEDICAL DEVICES REGULATIONS – ARE YOU PREPARED?

whitepaper

Jul 14, 2018

The publication of the stable text of the European Union (EU) Medical Devices Regulation, and the In Vitro Diagnostic Medical Devices Regulation in June 2016 documents the political agreement between the three EU Institutions – the Commission, the Parliament and the Council – on the cont...

Read More

Alzheimers Disease ALZHEIMERS DISEASE

whitepaper

Jul 12, 2018

Alzheimer’s Disease (AD) is the most common form of dementia and accounts for 60% to 80% of dementia cases. In this progressive disease, dementia symptoms gradually worsen over a number of years. Memory loss is mild during the early stages, but individuals with late-stage Alzheimer's lose ...

Read More

Opportunities in preclinical development OPPORTUNITIES IN PRECLINICAL DEVELOPMENT

whitepaper

Jul 11, 2018

This whitepaper explains how you can find ways to optimize the holistic preclinical development process. When it comes to informatics and data management, each preclinical domain is characterized by specific requirements due to their diverse scientific needs. This whitepaper explains how you can fin...

Read More

Healthcare Commerce as a User-Friendly Experience HEALTHCARE COMMERCE AS A USER-FRIENDLY EXPERIENCE

whitepaper

Jul 07, 2018

Technological advancements occur with such frequency that it’s challenging to stay on top — or ahead — of the Next Big Thing, but successful businesses need to focus attention on advancements that make internal processes easier and more efficient. Highly successful businesses take ...

Read More

2016 National Healthcare Quality  and Disparities Report 2016 NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORT

whitepaper

Jul 07, 2018

For the 14th year in a row, AHRQ is reporting on health care quality and disparities. The annual National Healthcare Quality and Disparities Report (QDR) is mandated by Congress to provide a comprehensive overview of the quality of health care received by the general U.S. population and disparities ...

Read More

Tufts CSDD-Veeva eClinical Study CRO Report TUFTS CSDD-VEEVA ECLINICAL STUDY CRO REPORT

whitepaper

Jul 06, 2018

See results from the Tufts eClinical Landscape Study – CRO Report on current data management practices, goals, and challenges for contract research organizations (CROs). Findings include. Anticipated growth and variety of data sources used by CROs. CROs’ biggest challenges with clinical ...

Read More

Your journey to cloud in healthcare YOUR JOURNEY TO CLOUD IN HEALTHCARE

whitepaper

Jul 05, 2018

As the cloud becomes more prevalent, healthcare leaders are finding themselves in a multi-cloud environment, moving beyond basic infrastructure on demand to strategic innovations such as running real-time data analytics for the management of chronic disease patients.

Read More

Ideas to Make Health Care Affordable Again IDEAS TO MAKE HEALTH CARE AFFORDABLE AGAIN

whitepaper

Jun 29, 2018

More Americans are concerned about health care costs (85%) that are concerned about other common worries like retirement (73%), housing (66%), and child care (49%).1 While Republicans, Democrats, and independents are divided over many healthcare issues, everyone agrees that the top health care prior...

Read More

Accelerating the Journey from Research to Clinic ACCELERATING THE JOURNEY FROM RESEARCH TO CLINIC

whitepaper

Jun 26, 2018

Bridging the gap from discovery to verification and validation requires high-performing instruments and software as well as competency in mass spec-based biomarker discovery and method development for biomarker verification. The Thermo Scientific™ Q Exactive™ HF-X mass spectrometer rises...

Read More

Regulatory Considerations for Incorporating PCID into SODF Drugs REGULATORY CONSIDERATIONS FOR INCORPORATING PCID INTO SODF DRUGS

whitepaper

Jun 23, 2018

Unauthorized diversion and falsification of drug products create safety risks in the supply chain, creating life-threatening risk for patients and reducing revenue, profitability and brand equity for drug owners. To reduce the proliferation of counterfeit drugs in the U.S., the Drug Quality and...

Read More

Mortality Data in Healthcare Analytics MORTALITY DATA IN HEALTHCARE ANALYTICS

whitepaper

Jun 19, 2018

The incorporation of mortality data into healthcare data sets allows fraud prevention, accurate billing, and benefits distribution, and true outcome analysis (especially in fatal disease areas like oncology, where survival is a key endpoint). The net effect of adding mortality data is strengthening ...

Read More

Improving Patient Matching with a Simple Plug-In IMPROVING PATIENT MATCHING WITH A SIMPLE PLUG-IN

whitepaper

Jun 19, 2018

Accurate patient matching is becoming 10 times more challenging and 10 times more critical. Instantly and dramatically improve your EHR’s or EMPI’s patient matching without disrupting any of its core functionality. By injecting the power of Referential Matching, you will get the full val...

Read More

Immuno-Oncology Advances in Applied Cellular Analysis IMMUNO-ONCOLOGY ADVANCES IN APPLIED CELLULAR ANALYSIS

whitepaper

Jun 18, 2018

For immuno-oncology research and the hunt for new immunotherapies, scientists are required to reliably quantify the functions and interactions of cancer cells and immune cells. Cell proliferation assays of tumor growth are a mainstay. Activation and proliferation assays for immune cells are also use...

Read More

Medical cost trend: Behind the numbers 2019 MEDICAL COST TREND: BEHIND THE NUMBERS 2019

whitepaper

Jun 16, 2018

Employer medical cost trend has plateaued. While the predictability is a welcome change from the wild swings and peak double-digit trends in the 2000s, steady as she goes is not good enough. Medical costs continue to grow as a percent of total employee compensation, making even the current trend uns...

Read More

Promoting Health, Preventing Disease PROMOTING HEALTH, PREVENTING DISEASE

whitepaper

Jun 15, 2018

The views expressed by authors or editors do not necessarily represent the decisions or the stated policies of the European Observatory on Health Systems and Policies or any of its partners. The designations employed and the presentation of the material in this publication do not imply the expressio...

Read More

Representative Analysis Results Require Adequate Sample Preparation REPRESENTATIVE ANALYSIS RESULTS REQUIRE ADEQUATE SAMPLE PREPARATION

whitepaper

Jun 15, 2018

The following situation is typical for many production plants: After a routine quality check, the production process is stopped or an already produced batch is suspended because the analysis results were not within the relevant critical values. But does the tested product really deviate from the spe...

Read More

The Impact of the Clinical Educator THE IMPACT OF THE CLINICAL EDUCATOR

whitepaper

Jun 12, 2018

From passive consumer to active participant, the role of the patient is changing as dramatically as the healthcare system itself. The fee-for-service, volume-based care of the past is giving way to a value-based care system focusing on quality and outcomes. The new system seeks to reduce skyroc...

Read More

Six Principles for Getting Pharmaceutical Development Right from the Start SIX PRINCIPLES FOR GETTING PHARMACEUTICAL DEVELOPMENT RIGHT FROM THE START

whitepaper

Jun 10, 2018

Pharmaceutical or biotechnology companies looking to outsource their API production are planning for success by looking at the entire development cycle. The growing desire to select one API partner to work with throughout the drug development process, and to potentially also synthesize commercial qu...

Read More

World health statistics 2018 WORLD HEALTH STATISTICS 2018

whitepaper

Jun 06, 2018

The World Health Statistics series is WHO’s annual compilation of health statistics for its 194 Member States. The series is produced by the WHO Department of Information, Evidence, and Research, of the Health Metrics and Measurement Cluster, in collaboration with all relevant WHO technical de...

Read More

Streamlining Patient Payment for Better Revenue Cycle Management STREAMLINING PATIENT PAYMENT FOR BETTER REVENUE CYCLE MANAGEMENT

whitepaper

Jun 06, 2018

Healthcare providers need to rethink their current patient payment collections strategy, thanks to two recent phenomena: high-deductible plans that are shifting a greater portion of the bill to the patient, and an increase in the number of patients struggling to pay those higher bills.

Read More

OPIOIDS AND PAIN: A PAN-EUROPEAN CHALLENGE OPIOIDS AND PAIN: A PAN-EUROPEAN CHALLENGE

whitepaper

Jun 06, 2018

The aim of this White Paper is to identify inequalities in government policies towards opioids that contribute to the inadequate treatment of pain. It calls for their replacement with policies that will support doctors and patients in their efforts to relieve pain.

Read More

Streamlining “Library-to-Lead” for your Antibody Therapeutics STREAMLINING “LIBRARY-TO-LEAD” FOR YOUR ANTIBODY THERAPEUTICS

whitepaper

Jun 06, 2018

The number of therapeutic antibodies entering the market continues to grow annually, with 2017 seeing ten approvals in either the European Union or the United States supported by a robust late-stage clinical pipeline that will likely yield even more approved drugs in 2018 and 2019. Making a drug is ...

Read More

Pricing Guide: Electronic Medical Records Software PRICING GUIDE: ELECTRONIC MEDICAL RECORDS SOFTWARE

whitepaper

Jun 05, 2018

When choosing an EMR system, you need to consider what you will be charged for and when, in addition to how much. This highly visual guide offers a clear explanation of how various pricing models work, along with actual pricing for popular EMR and Practice Management software packages.

Read More

THE FUTURE OF THE PHARMACEUTICAL INDUSTRY THE FUTURE OF THE PHARMACEUTICAL INDUSTRY

whitepaper

Jun 05, 2018

Ever participated in one of those benchmarking exercises? You know what I mean. When a (usually) fresh-faced consultant asks lots of questions and fills in a spreadsheet comparing what you do with your competitors. Well, beware. Trying to copy and follow others in a world of turbulence and massive u...

Read More

PATIENT-CENTERED HEALTH CARE VIA PATIENT-GENERATED HEALTH DATA PATIENT-CENTERED HEALTH CARE VIA PATIENT-GENERATED HEALTH DATA

whitepaper

Jun 05, 2018

Millennials are quickly becoming the dominant health care consumers, both for themselves, their families and as caregivers. Having grown up in a technology-first environment, however, they are increasingly dissatisfied with the static nature of health care options and are seeking out alternatives. N...

Read More

HOW TO EXTEND IDENTITY SECURITY TO YOUR API’S HOW TO EXTEND IDENTITY SECURITY TO YOUR API’S

whitepaper

May 25, 2018

The number of users and devices requesting access to applications is growing exponentially, and enterprises are scrambling to adapt their authentication and authorization infrastructure to deal with this fast growth. REST APIs are a critical new application access channel. In a sense, REST APIs are ...

Read More

Selecting the Right EHR for Your Practice SELECTING THE RIGHT EHR FOR YOUR PRACTICE

whitepaper

May 22, 2018

According to a recent study conducted by AmericanEHR, nearly 40 percent of physicians would not recommend their EHR solution to another provider; only slightly fewer said they would not purchase the same software again. Conversely, a study conducted this year by an EHR vendor, the approximately 60 p...

Read More

Patient Communication Guide PATIENT COMMUNICATION GUIDE

whitepaper

May 19, 2018

This guide outlines some simple strategies and tips for improving communication with your patients. Research indicates that ‘soft skills’ have a direct bearing on patient perceptions of the value of care provided, the degree of trust placed in the dentist and the success of treatment. Al...

Read More

Scalable Strategies For Parenteral Dosage Form Selection SCALABLE STRATEGIES FOR PARENTERAL DOSAGE FORM SELECTION

whitepaper

May 17, 2018

There are many parenteral dosage forms from which the pharmaceutical scientist can choose to develop their drug product. For primary pack choices, there are traditional vials, ampoules, cartridges, pre-filled syringes and complex containers such as the various types of dual chamber syringes. Additio...

Read More

Antibody Screening Solutions Made Easy ANTIBODY SCREENING SOLUTIONS MADE EASY

whitepaper

May 16, 2018

With breakthroughs in molecular engineering and antibody humanization, monoclonal antibodies (Mab) are one of the fastest-growing classes of biopharmaceuticals for multiple clinical indications including cancer, cardiovascular disease, autoimmune disorders, and infectious disease. Most therapeutic a...

Read More

Medicalchain MEDICALCHAIN

whitepaper

May 16, 2018

The information set forth below may not be exhaustive and does not imply any elements of a contractual relationship. While we make every effort to ensure that any material in this whitepaper is accurate and up to date, such as products, services, technical architecture, token distribution, company t...

Read More

Physician Advisor Programs: A Pillar of Thriving Provider Organizations PHYSICIAN ADVISOR PROGRAMS: A PILLAR OF THRIVING PROVIDER ORGANIZATIONS

whitepaper

May 15, 2018

By making use of external resources that assist in developing, implementing, and maintaining high-quality physician advisor programs, hospitals can improve their financial performance and ensure that patients receive the most appropriate care for their medical needs.

Read More

Manufacturing Of Sterile Aqueous Suspensions: A Primer MANUFACTURING OF STERILE AQUEOUS SUSPENSIONS: A PRIMER

whitepaper

May 15, 2018

Manufacturing of sterile aqueous suspensions requires the thorough understanding of the factors that influence their physical and chemical stability. Particle morphology of the active pharmaceutical ingredient (API) plays a key factor in drug product dissolution rate, resuspendability, and syringeab...

Read More

Pharma R&D Annual Review 2018 PHARMA R&D ANNUAL REVIEW 2018

whitepaper

May 15, 2018

Citeline’s Pharmaprojects’ Pharma R&D Annual Review 2018 is here! Tune into expert insights and score illuminating data on the trends that affected pharmaceutical R&D throughout 2017 and continue to shape the market today – for free.

Read More

Digital Healthcare Marketing and Engagement Solutions DIGITAL HEALTHCARE MARKETING AND ENGAGEMENT SOLUTIONS

whitepaper

May 10, 2018

Truven Health Analytics™ offers a full suite of digital marketing and engagement services and support for healthcare organizations. These services range from email list management and execution; to multilayered, multimodal, lead nurturing campaigns; to fully automated patient engagement messag...

Read More

Comparison of the articles of the European Medical Devices Directive (93/42/EEC) and the Medical Devices Regulation ((EU) 2017/745) COMPARISON OF THE ARTICLES OF THE EUROPEAN MEDICAL DEVICES DIRECTIVE (93/42/EEC) AND THE MEDICAL DEVICES REGULATION ((EU) 2017/745)

whitepaper

May 09, 2018

The MDR is significantly more comprehensive and detailed compared to the MDD. While the MDD comprises 23 Articles and 12 annexes over 60 pages, the MDR has 123 articles and 17 annexes over 175 pages. This table presents a summary of the provisions of some of the articles of the MDD and MDR together ...

Read More

Avoid Clinical Trial Enrollment Pitfalls AVOID CLINICAL TRIAL ENROLLMENT PITFALLS

whitepaper

May 06, 2018

Selecting the right site is the single most crucial decision
you’ll make about your next clinical trial. And perhaps the
single most important consideration in selecting a site is
whether it can make its enrollment. Many don’t; in fact,
20-25 percent of all cl...

Read More

Three Lessons Learned to Achieve Value-Based Care Success THREE LESSONS LEARNED TO ACHIEVE VALUE-BASED CARE SUCCESS

whitepaper

May 05, 2018

Commonwealth Physicians (Commonwealth)* is a physician-owned multi-specialty, the multi-location practice that serves more than 500,000 patients and is comprised of 25 practices and nearly 100 primary care providers. For Commonwealth Physicians, the Affordable  Care Act (ACA) created the impetu...

Read More

A new vision for comprehensive care coordination A NEW VISION FOR COMPREHENSIVE CARE COORDINATION

whitepaper

May 05, 2018

Transitioning patients between outpatient, inpatient, post-acute and home settings can be a major challenge for hospitals. For organizations participating in value-based reimbursement models, it can also be costly. This case study examines how Holyoke (Mass.) Medical Center redesigned its care manag...

Read More

A Framework for Building Trust and Collaboration Between Health Plans and Physicians A FRAMEWORK FOR BUILDING TRUST AND COLLABORATION BETWEEN HEALTH PLANS AND PHYSICIANS

whitepaper

May 05, 2018

One of the best ways to maximize revenue under value-based care arrangements is for health plans and physicians to team up and work collaboratively on health care transformation. By building a strong and meaningful partnership, health plans and physicians can achieve higher quality, provider better ...

Read More

EPIC FAIL: FIVE PROVEN WAYS TO BOTCH YOUR SUPPLIER RELATIONSHIP MANAGEMENT PROGRAM EPIC FAIL: FIVE PROVEN WAYS TO BOTCH YOUR SUPPLIER RELATIONSHIP MANAGEMENT PROGRAM

whitepaper

May 04, 2018

Supplier Relationship Management (SRM) is not a new concept, but it has been growing in importance. The theory is that SRM helps enterprises drive value in both recessionary periods – like that of the last few years – by enabling cost reductions, and also in high growth phases by support...

Read More

THE FUTURE OF DIGITAL HEALTH THE FUTURE OF DIGITAL HEALTH

whitepaper

May 02, 2018

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution. The importance of successfully executing a digital health strategy, as well as creating new financial models and partnerships, cannot be under...

Read More

Navigating Patient Payment Conversations with Financial Counseling NAVIGATING PATIENT PAYMENT CONVERSATIONS WITH FINANCIAL COUNSELING

whitepaper

May 01, 2018

Many healthcare organizations depend on the work of financial counselors to help patients understand both their insurance coverage and their financial obligations. These professionals help patients make smart choices by answering questions about the cost of healthcare services, setting up payment pl...

Read More

Pharma Consulting Whitepaper PHARMA CONSULTING WHITEPAPER

whitepaper

Apr 30, 2018

Accurate benchmarking has never been more important to the biopharma industry than now, with increased scrutiny related to development costs at an all-time high. What benchmarks are you using? How does your development program compare to those of your competitors? Explore the importance of benchmark...

Read More

Is China the Dark Horse in Clinical Development IS CHINA THE DARK HORSE IN CLINICAL DEVELOPMENT

whitepaper

Apr 30, 2018

Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D, with a rich pipeline of new drugs and robust clinical trial activities

Read More

Digital Pathology in Accelerating Drug Development DIGITAL PATHOLOGY IN ACCELERATING DRUG DEVELOPMENT

whitepaper

Apr 25, 2018

Tissue pathology is at the core of various aspects of the pharmaceutic pipeline. Digital pathology is a technology that converts glass microscope slides with tissue samples into whole slide digital images, which can be used to identify, quantify, and document key characteristics of tissue samples. T...

Read More

8 reasons why it’s time to upgrade to automated imaging 8 REASONS WHY IT’S TIME TO UPGRADE TO AUTOMATED IMAGING

whitepaper

Apr 25, 2018

Automated image analysis systems that provide detailed morphological information are rapidly replacing manual microscopy as the most effective method of characterizing both particle shape and size. These sophisticated new instruments use the latest technology to provide useful and actionable insight...

Read More

The Use of EDXRF for Pharmaceutical Material Elemental Analysis THE USE OF EDXRF FOR PHARMACEUTICAL MATERIAL ELEMENTAL ANALYSIS

whitepaper

Apr 24, 2018

The recent changes to the United States Pharmacopeia (USP) regarding requirements for elemental impurity testing has peaked interest into new ways to perform this testing. Combining these new requirements with the introduction of USP chapter <735> X-ray fluorescence spectrometry1 permits a new...

Read More

Analysis of Microplastics using FTIR Imaging ANALYSIS OF MICROPLASTICS USING FTIR IMAGING

whitepaper

Apr 19, 2018

As plastics continue to enter the environment, understanding their global impact is vital to addressing microplastic pollution. Since its emergence as an environmental and potential human health threat, researchers have strived to develop tools for accurately measuring microplastics in environmental...

Read More

Asthma- and COPD-related Differential Gene Expression in Primary Human Lung Fibroblasts ASTHMA- AND COPD-RELATED DIFFERENTIAL GENE EXPRESSION IN PRIMARY HUMAN LUNG FIBROBLASTS

whitepaper

Apr 06, 2018

With the prevalence of asthma and chronic obstructive pulmonary disease (COPD) growing worldwide, the availability of primary human cells from these respiratory diseases is critical to increasing research and knowledge about the disease at a cellular level. In this study, we sought to identify genes...

Read More

ALIGNING STAKEHOLDERS IN A NEW HEALTHCARE ECOSYSTEM ALIGNING STAKEHOLDERS IN A NEW HEALTHCARE ECOSYSTEM

whitepaper

Apr 05, 2018

Preventable chronic diseases such as diabetes, cardiovascular disease, and cancers are responsible for over 40 of the 56 million annual deaths worldwide (7 out of every 10 deaths). Our medical communities spend vast resources battling complications of these behavior-related conditions, despite the a...

Read More

2018 JP Morgan Healthcare Conference Review 2018 JP MORGAN HEALTHCARE CONFERENCE REVIEW

whitepaper

Apr 05, 2018

Don't miss out on this comprehensive review of all the presentations from the conference, compiled by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this repo...

Read More

Discriminating insulin analogs with liquid chromatography-mass spectrometry DISCRIMINATING INSULIN ANALOGS WITH LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY

whitepaper

Apr 04, 2018

There is currently a half-dozen different insulin analogues on the market. These differ from each other and from natural insulin by just a few amino acids but exhibit markedly different pharmacokinetic and pharmacodynamic properties. Liquid chromatography and mass spectrometry (LC-MS) offers a power...

Read More

The value of full-length transcripts without bias THE VALUE OF FULL-LENGTH TRANSCRIPTS WITHOUT BIAS

whitepaper

Mar 28, 2018

RNA sequencing (referred to as RNA-Seq with traditional sequencing technologies) has led to unprecedented advances in all fields of biology and medicine. It has been an invaluable tool for the study of human genetics and the pathology associated with the disease. Transcript isoform expression and us...

Read More

Novel Biologics - Asthma NOVEL BIOLOGICS - ASTHMA

whitepaper

Mar 22, 2018

Download this white paper, which looks at novel biologics in development for the treatment of uncontrolled, eosinophilic asthma and whether they can fulfill the promise of truly targeted therapies for one of the most prevalent respiratory diseases worldwide. Novel Biologics for Asthma: Steps on the ...

Read More

Product Lifecycle Management for the Pharmaceutical Industry PRODUCT LIFECYCLE MANAGEMENT FOR THE PHARMACEUTICAL INDUSTRY

whitepaper

Mar 21, 2018

In recent years the pharmaceutical industry has faced declining R&D productivity, a rapidly changing healthcare landscape and fierce competition from generics resulting in lower growth and profit margins. Historically, drug development focused on clinical trials management and outcomes. Now howe...

Read More

The Benefits of Aqueous Critical Cleaning THE BENEFITS OF AQUEOUS CRITICAL CLEANING

whitepaper

Mar 20, 2018

Aqueous cleaners are typically formulated to ensure maximal cleaning performance by using key ingredients such as surface active agents (surfactants) excellent wetting agents that allow the cleaning solution to penetrate into crevices while getting under soils to allow for removal. Often very dilute...

Read More

AN ANALYSIS OF DRUG THERAPY TAPERING GUIDELINES AN ANALYSIS OF DRUG THERAPY TAPERING GUIDELINES

whitepaper

Mar 16, 2018

Chronic pain, the kind of pain a person wakes up with every morning and goes to sleep with every night, has a standard of care that is often incomplete and sometimes inaccurate. Chronic pain treatment often revolves around drug therapy and managing side effects without addressing non-drug therapies ...

Read More

Analysis Using Counter-rotating Twin Screw Extruder ANALYSIS USING COUNTER-ROTATING TWIN SCREW EXTRUDER

whitepaper

Mar 14, 2018

While the co-rotating, intermeshing TSE is more commonly used in pharmaceutical R&D and production, the counter-rotating, intermeshing TSE is a viable tool to successfully process these formulations. Energy input must be strategically balanced to perform mixing functions without degradation of A...

Read More

Patheon’s Solid and Sterile Dosage Forms Brochure PATHEON’S SOLID AND STERILE DOSAGE FORMS BROCHURE

whitepaper

Mar 14, 2018

By partnering with Patheon, you have access to a remarkable range of dosage form technologies for oral solids. Take advantage of our expansive scientific resources and expertise to create a product that stands out in the marketplace. For more information about specific dosage forms, as well as where...

Read More

Next-Gen Therapeutics Begin with Targeted Sequencing NEXT-GEN THERAPEUTICS BEGIN WITH TARGETED SEQUENCING

whitepaper

Mar 13, 2018

A major step towards personalized medicine was achieved in early 2014 when the first report of sequencing a human genome for $1,000 was announced—hailed by some as one of the greatest scientific and medical achievements of the last decade.

Read More

Recent Trends in Personalized Medicine RECENT TRENDS IN PERSONALIZED MEDICINE

whitepaper

Mar 10, 2018

Top Country Involvement in Ongoing Oncology PGX Trials. Emerging Trend: Epigenetics. Unexpected Advantages and Potential Pitfalls of Using PGX Selection. Top Sponsors of Ongoing or Planned Oncology Trials. What's on the Horizon for Pharmacogenetics and Epigenetics in Drug Development

Read More

High capacity containment check screening HIGH CAPACITY CONTAINMENT CHECK SCREENING

whitepaper

Mar 10, 2018

This paper will discuss the aspects of bioburden reduction in a manufacturing area or cleanroom during operational shutdown or for routine maintenance scheduling. Relevant regulatory requirements are overviewed, along with the factors constituting aseptic cleaning. What is aseptic cleaning? Asepsis ...

Read More

Japanese Pharmaceutical Market JAPANESE PHARMACEUTICAL MARKET

whitepaper

Mar 07, 2018

Pharmaceutical companies face many challenges in Japan in terms of it's complex regulatory and pricing process. Regular price cuts also pose hurdles for the introduction of new innovative drugs. Despite these challenges, the world’s second largest pharmaceutical market presents a number of...

Read More

A Recent History of Antibiotics and Where We May Be Going A RECENT HISTORY OF ANTIBIOTICS AND WHERE WE MAY BE GOING

whitepaper

Mar 01, 2018

About Clinical Research Management, Inc. Clinical Research Management (ClinicalRM) is not only involved in the testing of new antibiotics in Phase I, II, III studies, monitoring protocol development, site selection, and assistance with FDA approvals, but is also involved in responding to the challen...

Read More

Understand and optimize the cleanliness of your critically controlled environment. UNDERSTAND AND OPTIMIZE THE CLEANLINESS OF YOUR CRITICALLY CONTROLLED ENVIRONMENT.

whitepaper

Feb 27, 2018

Maintaining specific levels of cleanliness in controlled environments is extremely difficult. It’s even more difficult when an assortment of cleaning tools are utilized. Standard operating procedures become unnecessarily complex and difficult to meet. Cleaning becomes cumbersome, and the resul...

Read More

Orthogonal and complementary nanoparticle characterization techniques ORTHOGONAL AND COMPLEMENTARY NANOPARTICLE CHARACTERIZATION TECHNIQUES

whitepaper

Feb 26, 2018

How can I trust my data? This is a common concern for many researchers using particle measurement instrumentation. Is the data affected in any way by the measurement technology, or alternatively by the user during sample preparation or by the analysis parameters employed? To answer this question we ...

Read More

High-Throughput & Phenotypic Screening HIGH-THROUGHPUT & PHENOTYPIC SCREENING

whitepaper

Feb 22, 2018

Screening is an essential method for analyzing a group of chemicals, molecules, and/or compounds for a particular function in a prescribed assay. Proper screening is important for the identification of meaningful associations between compounds and targets, and screening technology has significantly ...

Read More

4 Pillars Pharma Distributors Can Stand On 4 PILLARS PHARMA DISTRIBUTORS CAN STAND ON

whitepaper

Feb 21, 2018

Despite a recent global economic downturn, the world pharmaceutical market is currently estimated to be valued at around $300 billion and rising, according to the World Health Organization (WHO). In a recent post, the WHO states that more than a third of the market is controlled by 10 large drug com...

Read More

Using Technology to Revolutionize the Health Care Industry USING TECHNOLOGY TO REVOLUTIONIZE THE HEALTH CARE INDUSTRY

whitepaper

Feb 18, 2018

What if we could focus interventions on the exact group that can be most impacted? Target those that can benefit most from a particular series of actions? Identify transient patients so they could be intensely targeted before they move on? Effectively manage high-risk patients to reduce costs? This ...

Read More

As Heal revolutionizes healthcare, Okta takes care of identity management AS HEAL REVOLUTIONIZES HEALTHCARE, OKTA TAKES CARE OF IDENTITY MANAGEMENT

whitepaper

Feb 18, 2018

At first, users had to remember different passwords for each application, and provisioning and managing accounts was a cumbersome, manual IT task. In addition, compliance with the Health Insurance Portability and Accountability Act (HIPAA) in Heal’s mobile, 100% cloud environment would require...

Read More

The rise of mobile working in healthcare – exploring the benefits, the barriers and the opportunities THE RISE OF MOBILE WORKING IN HEALTHCARE – EXPLORING THE BENEFITS, THE BARRIERS AND THE OPPORTUNITIES

whitepaper

Feb 17, 2018

At Digital Health, we provide unparalleled insight into the world of NHS IT. It is little wonder that, in recent years, an increasing amount of our work has centered on the use of mobile technology in healthcare. As smartphones and tablets have revolutionized our day-to-day lives, so too do the...

Read More

Transforming care for patients as consumers TRANSFORMING CARE FOR PATIENTS AS CONSUMERS

whitepaper

Feb 14, 2018

Patients are increasingly behaving like consumers in a healthcare setting. As a result, they expect enhanced services and experiences when engaging with providers and health systems. How can health systems engage patients in an integrated effort that aligns with strategic goals to improve patient ou...

Read More

TRACK & TRACE IN THE PHARMACEUTICAL INDUSTRY TRACK & TRACE IN THE PHARMACEUTICAL INDUSTRY

whitepaper

Feb 13, 2018

The pharmaceutical industry is not short of challenges patent cliffs, regulatory scrutiny, and R&D productivity, as well as a complex supply chain. Pharmaceutical products see several changes of hands from the manufacturers to distributors to dispensers and, finally, the patients allowing easy e...

Read More

Neural Stem Cells NEURAL STEM CELLS

whitepaper

Feb 09, 2018

The mature mammalian central nervous system (CNS) is composed of three major differentiated cell types: neurons, astrocytes, and oligodendrocytes. Neurons transmit information through action potentials and neurotransmitters to other neurons, muscle cells or gland cells. Astrocytes and oligodendrocyt...

Read More

Best Practices in Cloud Computing for Healthcare BEST PRACTICES IN CLOUD COMPUTING FOR HEALTHCARE

whitepaper

Feb 02, 2018

Healthcare providers face a variety of resource, compliance, security, cost, reimbursement, and integration challenges that have not only strained hospital IT departments but also have affected they way clinicians provide care

Read More

Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs CHOOSING THE BEST STERILE DOSAGE FORM FOR YOUR PHASE I CLINICAL SUPPLY NEEDS

whitepaper

Jan 20, 2018

There are many parenteral dosage forms from which the pharmaceutical scientist can choose to develop their drug product. For primary pack choices, there are traditional vials, ampoules, cartridges, pre-filled syringes and complex containers such as the various types of dual chamber syringes.

Read More

Pharma R&D Annual Review 2017 PHARMA R&D ANNUAL REVIEW 2017

whitepaper

Jan 12, 2018

Welcome to Pharmaprojects’ 2017 review of trends in pharmaceutical R&D. For around a quarter of a century now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’ll look at how the land lies at the start of 2017. We’ll assess indust...

Read More

Population Health Management: Optimizing Pharmacy’s Capacity for Value-Based Patient Care POPULATION HEALTH MANAGEMENT: OPTIMIZING PHARMACY’S CAPACITY FOR VALUE-BASED PATIENT CARE

whitepaper

Jan 10, 2018

This whitepaper addresses value-based health care as a driver of Population Health Management (PHM), the integral role of pharmacy-based Population Health Management, and strategies for optimizing patient care capacity to improve health outcomes and lower costs of patient care.

Read More

Finding Value in Volume - Applications of Big Data Analytics FINDING VALUE IN VOLUME - APPLICATIONS OF BIG DATA ANALYTICS

whitepaper

Jan 08, 2018

Learn how predictive data analytics can drive new breakthroughs, accelerate big data solutions, and derive insights from publicly available data with this eBook from The Scientist and PerkinElmer, Inc. Thanks to technology, scientific research can now generate more data than ever before. Howeve...

Read More

Healthcare Analytics Platform: DOS Delivers the 7 Essential Components HEALTHCARE ANALYTICS PLATFORM: DOS DELIVERS THE 7 ESSENTIAL COMPONENTS

whitepaper

Jan 07, 2018

Population health, value-based care, decreasing revenues, and increasing costs are just a few of the pivotal issues challenging healthcare IT leaders today. Among other requirements, these issues call for large amounts of data, real-time data access, scalable analytics platforms, and systems interop...

Read More

Medical Research Law & Policy Report MEDICAL RESEARCH LAW & POLICY REPORT

whitepaper

Jan 03, 2018

Will the 21st Century Cures Act further its aim to boost drug and device development in 2018? That's one of the questions the life sciences industry and attorneys are asking for the new year. The law provides extra money for research and development including ambitious research into cancer and a...

Read More

How Label Verification Reduces Pharmaceutical Recall Costs HOW LABEL VERIFICATION REDUCES PHARMACEUTICAL RECALL COSTS

whitepaper

Dec 21, 2017

The Drug Supply Chain Security Act (DSCSA) has been on the mind of pharmaceutical manufacturers since it was enacted in 2013, and the latest requirements are rapidly approaching. Beginning in November 2017, manufacturers will be expected to mark their products with a National Drug Code (NDC), Serial...

Read More

Reforming Biopharmaceutical Pricing at Home and Abroad REFORMING BIOPHARMACEUTICAL PRICING AT HOME AND ABROAD

whitepaper

Nov 23, 2017

The affordability of healthcare and biopharmaceutical drugs is a top concern for Americans. It is often asserted that promoting innovation and affordable drugs are conflicting goals. New innovations, however, often provide improved health that was not previously available at any price or obviate the...

Read More

Rethinking Pharma from the Outside In RETHINKING PHARMA FROM THE OUTSIDE IN

whitepaper

Nov 22, 2017

The U.S. healthcare ecosystem has faced a myriad of changes in just the last decade, and pharmaceutical companies continue to face the effects of those changes. The players have become more diverse, and today’s target audience for pharmaceuticals has expanded to include healthcare organization...

Read More

Application note: Verification of pharmaceutical raw materials using the Spectrum Two N FT-NIR Spectrometer APPLICATION NOTE: VERIFICATION OF PHARMACEUTICAL RAW MATERIALS USING THE SPECTRUM TWO N FT-NIR SPECTROMETER

whitepaper

Nov 01, 2017

Near-infrared (NIR) spectroscopy is an important technique for materials checking at various stages of the manufacturing process but is particularly useful at the raw materials inspection stage. Raw materials come in a variety of physical forms including liquids, gels, and solids, requiring a versat...

Read More

A Better Prescription for Reducing Medication Errors and
Maximizing the Value of Clinical Decision Support A BETTER PRESCRIPTION FOR REDUCING MEDICATION ERRORS AND MAXIMIZING THE VALUE OF CLINICAL DECISION SUPPORT

whitepaper

Oct 30, 2017

Medication errors remain an unnecessary public health menace. While industry awareness of the problem has existed for some time, efforts to reduce the incidence and impact of medication errors have not yet yielded much success. Consequently, the significant patient harm, death toll, and economic bur...

Read More

New insights into large genomes NEW INSIGHTS INTO LARGE GENOMES

whitepaper

Oct 18, 2017

Since Haemophilus influenzae became the first organism to have its entire genome sequenced in 19951 , there are now thousands of completed genomes covering archaea, bacteria and eukarya. However, the term ‘completed genome’ (or sometimes ‘finished genome’) is overused, as the...

Read More

Accelerating precision medicine ACCELERATING PRECISION MEDICINE

whitepaper

Oct 17, 2017

The fully realized vision of precision medicine includes the capability to rapidly diagnose, sequence and develop a personalized treatment plan based on combined analysis of genotype, phenotype, environmental, clinical and behavioral data. Precision medicine can be advanced through the “All of...

Read More

The Scientific Path To Cycle Development THE SCIENTIFIC PATH TO CYCLE DEVELOPMENT

whitepaper

Oct 17, 2017

Management of medication delivery through lyophilization - freeze-drying - is a crucial enabling process technology for many important parenteral drugs. Close to 50% of biopharmaceuticals, including enzymes, proteins and monoclonal antibodies, must be lyophilized as these therapeutic agents are insu...

Read More

The National Pharmaceutical Strategy 2016 2018 THE NATIONAL PHARMACEUTICAL STRATEGY 2016 2018

whitepaper

Oct 16, 2017

The Government and the Swedish Association of Local Authorities and Regions, together with a broad set of pharmaceutical actors, have agreed to continue to build on and enhance the work that has been in progress for several years under the National Pharmaceutical Strategy (NPS). There is a consensus...

Read More

Liposome Technology LIPOSOME TECHNOLOGY

whitepaper

Oct 09, 2017

Polymun offers the development of liposomal formulations for all kinds of pharmaceutically active ingredients and vaccine antigens. A broad spectrum of analytical methods has been established for this purpose. Polymun produces GMP material including all necessary documentation for IMPD/IND. We also ...

Read More

De-Risking Antibiotic Drug Development with PK-PD DE-RISKING ANTIBIOTIC DRUG DEVELOPMENT WITH PK-PD

whitepaper

Oct 05, 2017

Pharmacometrics, which includes the science of pharmacokinetics-pharmacodynamics (PK-PD), is one of the most commonly misunderstood, misused, and under-appreciated resources available to drug developers. In the past PK-PD was an afterthought, but today it is required by regulators and here’s w...

Read More

Lysosomal Storage Disorders LYSOSOMAL STORAGE DISORDERS

whitepaper

Oct 05, 2017

The aim of this hospital-based retrospective analysis is to estimate the prevalence of Lysosomal Storage Disease (LSDs) in the Eastern Province of Saudi Arabia between 1983 and 2016. A total number of 89 Saudi patients from 43 families were diagnosed with different types of LSDs within this time per...

Read More

Access controls for medical devices ACCESS CONTROLS FOR MEDICAL DEVICES

whitepaper

Sep 27, 2017

Healthcare information technology has quickly become one of a clinician’s most powerful instruments. The implementation of technology to automate the collection and documentation of patient information, such as vital signs, continues to expand to users in more care settings within the hospital...

Read More

The BlockRx pharma Ecosystem THE BLOCKRX PHARMA ECOSYSTEM

whitepaper

Sep 21, 2017

BlockRx is a series of initiatives presented by iSolve, a privately owned Blockchain solution provider for the Life Sciences Industry. The mission of BlockRx is to interconnect systems that do not readily communicate, establish data provenance that satisfies regulatory and business requirements, and...

Read More

4 Factors Critical to the Financial Success of an Emerging Pharmaceutical Company 4 FACTORS CRITICAL TO THE FINANCIAL SUCCESS OF AN EMERGING PHARMACEUTICAL COMPANY

whitepaper

Sep 20, 2017

Fascinating developments within the biopharmaceutical sector have been grabbing industry headlines for years now. The field is exciting and developing rapidly. However, the reality is that small, synthetic molecules remain critically important to both drug development pipelines and the market.

Read More

Life Sciences Manufacturing and Quality: The New Path to Performance LIFE SCIENCES MANUFACTURING AND QUALITY: THE NEW PATH TO PERFORMANCE

whitepaper

Sep 11, 2017

Life Sciences companies are attempting to improve compliance and manufacturing efficiency while they drive to grow revenue and margins. However, current market conditions are creating substantial headwinds to attaining these targets. S

Read More

Regulatory compliance in pharma – software requirements and solutions REGULATORY COMPLIANCE IN PHARMA – SOFTWARE REQUIREMENTS AND SOLUTIONS

whitepaper

Sep 01, 2017

The Drug Supply Chain Security Act (DSCSA) has been on the mind of pharmaceutical manufacturers since it was enacted in 2013, and the latest requirements are rapidly approaching. Beginning in November 2017, manufacturers will be expected to mark their products with a National Drug Code (NDC), Serial...

Read More

Value-Based Contracting for Oncology Drugs VALUE-BASED CONTRACTING FOR ONCOLOGY DRUGS

whitepaper

Aug 29, 2017

A revolution is occurring in cancer treatment, based on new insights into the biology of cancer, and resulting in dozens of new drugs on the market or in the development pipeline. Many of these new drugs are “targeted” therapies that are tailored to the specific genetics and molecular pa...

Read More

Agile Process Development In Biopharmaceuticals AGILE PROCESS DEVELOPMENT IN BIOPHARMACEUTICALS

whitepaper

Aug 23, 2017

The development of novel therapeutic products involves a complex network of internal departments and external partners. Different groups across Process Development organizations typically use a variety of approaches to capture, manage, analyze and report data. These can range from paper and Excel to...

Read More

BREAST CANCER DRUGS FUNDING AND TRIALS BREAST CANCER DRUGS FUNDING AND TRIALS

whitepaper

Aug 01, 2017

This white paper arises out of the Pink Ribbon drugs funding & trials conference, held at the faculty of pharmaceutical medicine on 23 March 2017 (full programme provided on page 13-15). The general theme to emerge from the conference is that the UK would benefit from enhanced communication betw...

Read More

An Overview Of The ICH-Q3D Heavy Metal Regulations AN OVERVIEW OF THE ICH-Q3D HEAVY METAL REGULATIONS

whitepaper

Jul 14, 2017

The presence of residual metal impurities during drug manufacturing has become a major issue in the pharmaceutical industry in recent years, prompting a wide amount of interest in solutions for their safe and efficient removal.

Read More

Big Data Lipidomics for Lipid Biomarker Identification and Drug Discovery BIG DATA LIPIDOMICS FOR LIPID BIOMARKER IDENTIFICATION AND DRUG DISCOVERY

whitepaper

Jul 04, 2017

At Lipotype our expertise are lipids, lipid metabolism, lipid chemistry and lipidomics. Therefore, statistical analysis is always done with this knowledge as a basis. We treat lipids not as isolated entities but as a metabolic network with substructure and with their functions in mind. At Lipotype w...

Read More

Silicones for pharmaceutical applications analytical capabilities at Solvias SILICONES FOR PHARMACEUTICAL APPLICATIONS ANALYTICAL CAPABILITIES AT SOLVIAS

whitepaper

Jun 21, 2017

Silicones are used in pharmaceutical applications as part of formulations, as well as during manufacturing and in packaging. The term ‘silicones’ encompasses a large number of compounds based on polydialkylsiloxanes. The most common are trimethylsilyloxy-terminated polydimethylsiloxanes....

Read More

Sponsor CRO Pharmacovigilance Alliances White Paper SPONSOR CRO PHARMACOVIGILANCE ALLIANCES WHITE PAPER

whitepaper

Jun 21, 2017

Outsourcing pharmacovigilance activities is a standard business practice in a continuously expanding market segment. In the past, outsourced safety services were limited due to concerns about confidentiality, data security, and liability in cases of regulatory non-compliance, which are all still imp...

Read More

The Pharmaceutical Blockchain of Value Digital Token Launch THE PHARMACEUTICAL BLOCKCHAIN OF VALUE DIGITAL TOKEN LAUNCH

whitepaper

Jun 20, 2017

Drug manufacturers currently do not have an effective way to securely, transparently, and rapidly track the provenance of drugs or to access the data required to combat counterfeit drug sales. (1) As a result, they are unable to decrease the time and cost it takes to bring life-saving drugs to marke...

Read More

Pharmacy at a glance PHARMACY AT A GLANCE

whitepaper

Jun 20, 2017

For the 2017 survey,the maximum sample size- the number of countries and territories with at least one FIP member organisation or candidate member organisation at the time of the survey.

Read More

Oracle’s Unified Cloud Platform Promises to Shorten Clinical Trials ORACLE’S UNIFIED CLOUD PLATFORM PROMISES TO SHORTEN CLINICAL TRIALS

whitepaper

Jun 19, 2017

Oracle’s Clinical One Platform will enable pharmaceutical companies to manage every trial function from randomizing patient participants and collecting and analyzing data to tracking budgets and ensuring trial safety from a single user interface.

Read More

THE FUTURE OF LIFE SCIENCES AND HEALTHCARE LOGISTICS THE FUTURE OF LIFE SCIENCES AND HEALTHCARE LOGISTICS

whitepaper

Jun 17, 2017

From 2015 to 2019, global healthcare spending is expected to increase by 4.3% annually. Along with growth, the sector is going through the significant transformation of its operating models and supply chains. These include three key developments: First, there are significant pressures from governmen...

Read More

Pharmaceutical Innovation Index 2017 PHARMACEUTICAL INNOVATION INDEX 2017

whitepaper

Jun 14, 2017

The most eye-catching change in innovation for 2016 from the previous year was the fall in the number of new agents approved by the FDA, 22 for 2016 versus 41 and 45 in 2014 and 2015 respectively. Five agents being licensed at the end of 2015, plus the large number of complete response letters issue...

Read More

Whitepaper: Raman Hyperspectral Imaging – An essential tool in the pharmaceutical field WHITEPAPER: RAMAN HYPERSPECTRAL IMAGING – AN ESSENTIAL TOOL IN THE PHARMACEUTICAL FIELD

whitepaper

Jun 12, 2017

In the pharmaceutical environment, and especially in the research and development field, the quality of the medicine is a critical step as it is facing challenges with increased? demand from the regulatory affairs to improve the quality of a pharmaceutical drug product. In order to ensure its proper...

Read More

ANALYSIS OF EXTRACTABLES AND LEACHABLES ANALYSIS OF EXTRACTABLES AND LEACHABLES

whitepaper

Jun 08, 2017

Manufacturers of pharmaceuticals, drug delivery systems, and biomedical devices have come under growing pressure to perform sensitive and accurate analytical studies to detect, identify, and quantify extractable and leachable compounds (E&Ls). E&Ls may be inherently toxic or may contaminate ...

Read More

2016 Clinical trials roundup: Steady Course or changing tides? 2016 CLINICAL TRIALS ROUNDUP: STEADY COURSE OR CHANGING TIDES?

whitepaper

Jun 01, 2017

Round-up of the 2015 debuts; Distribution of phases of unapproved drug trials per therapeutic area in 2015; Top 25 disease by trial count Top locations for unapproved drug trials starting in 2015; Average number of countries disclosed per trial across most active industry sponsors

Read More

US Pharma’s Business Model: Why It Is Broken, and How It Can Be Fixed US PHARMA’S BUSINESS MODEL: WHY IT IS BROKEN, AND HOW IT CAN BE FIXED

whitepaper

May 22, 2017

Price gouging in the US pharmaceutical drug industry goes back more than three decades. In 1985 US Representative Henry Waxman, chair of the House Subcommittee on Health and the Environment, accused the pharmaceutical industry of “gouging the American public” with “outrageous&rdquo...

Read More

Solving Complex Pharmaceuticals Dosing Tasks SOLVING COMPLEX PHARMACEUTICALS DOSING TASKS

whitepaper

May 18, 2017

In the field of dosing and filling in the pharmaceutical industry, one usually thinks of waterlike, non-viscous products such as solutions used for injecting. For the most part, these can be filled with a high degree of process reliability using hose pumps, rotary piston pumps and time pressure syst...

Read More

Applications in Pharmaceutical Manufacturing APPLICATIONS IN PHARMACEUTICAL MANUFACTURING

whitepaper

May 18, 2017

The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefi ts in terms of effectiveness, minimal surface residue, and easier cleaning validation. Virtually any pharmaceutical manufacturing equipment — from tablet presses to a stainless steel mixing tanks — can be cleane...

Read More

White paper - Cancer medicines shortages in Europe WHITE PAPER - CANCER MEDICINES SHORTAGES IN EUROPE

whitepaper

May 17, 2017

Access to medicines for cancer patients is crucial for providing high quality care. However, cancer medicines shortages are a problem affecting countries across Europe. These shortages occur when the supply of medicines, identified as essential by the health system, is insufficient to meet public he...

Read More

Cancer medicines shortages in Europe Policy recommendations to prevent and manage shortages CANCER MEDICINES SHORTAGES IN EUROPE POLICY RECOMMENDATIONS TO PREVENT AND MANAGE SHORTAGES

whitepaper

May 17, 2017

Access to medicines for cancer patients is crucial for providing high quality care. However, cancer medicines shortages are a problem affecting countries across Europe. These shortages occur when the supply of medicines, identified as essential by the health system, is insufficient to meet public he...

Read More

Improving How Physicians Deliver Patient Care IMPROVING HOW PHYSICIANS DELIVER PATIENT CARE

whitepaper

May 05, 2017

This IDC White Paper, sponsored by Pure Storage, discusses important healthcare IT storage needs for the growing provider market, focusing on how all-flash storage solutions can be used to provide faster access to patient data. Patient data includes both structured and unstructured data, including h...

Read More

The Anatomy of Healthcare Delivery Model THE ANATOMY OF HEALTHCARE DELIVERY MODEL

whitepaper

Apr 04, 2017

Healthcare in the United States is and always has been a complex system. This complexity is ever increasing as value-based purchasing and population health management transform our hospital-centric industry into one focused on the continuum of care.`

Read More

How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial HOW TO MITIGATE THE RISK OF SELECTING A NON-ENROLLING SITE FOR YOUR CLINICAL TRIAL

whitepaper

Mar 23, 2017

Other than skin cancer, prostate cancer is the most common cancer in American men with about one in seven receiving a prostate cancer diagnosis during his lifetime.

Read More

Pharmacy’s global transformation is pharma’s opportunity PHARMACY’S GLOBAL TRANSFORMATION IS PHARMA’S OPPORTUNITY

whitepaper

Mar 15, 2017

Pharmacy’s role is expanding from supply chain to primary care, from intermediary and retailer to expert advisor in health and wellness. From the developing nations of India and China to more-developed markets like the UK, this evolution is accelerating, with Pharmacists poised to emerge as pr...

Read More

Accelerating Science Using Integrated PCR Tools ACCELERATING SCIENCE USING INTEGRATED PCR TOOLS

whitepaper

Feb 15, 2017

Thomas Edison once said, “The doctor of the future will give no medicine but will interest his patients in the care of the human frame, in diet, and in the cause and prevention of disease.” Since then, we have indeed moved in that direction, especially with the growth of health maintenan...

Read More

Chemistry for Better Health CHEMISTRY FOR BETTER HEALTH

whitepaper

Feb 11, 2017

The annual Chemical Sciences and Society Summit (CS3) brings together the best minds in chemical science research from around the world and challenges them to propose innovative solutions for society’s most pressing needs in the areas of health, food, energy, and the environment. This unique e...

Read More

Pharma R&D Annual Review 2017 PHARMA R&D ANNUAL REVIEW 2017

whitepaper

Feb 03, 2017

Welcome to Pharmaprojects’ 2017 review of trends in pharmaceutical R&D. For around a quarter of a century now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’ll look at how the land lies at the start of 2017. We’ll assess indust...

Read More

Healthcare fraud prevention partnership HEALTHCARE FRAUD PREVENTION PARTNERSHIP

whitepaper

Jan 30, 2017

Prescription opioid misuse and opioid use disorder (OUD) are significant and growing public health problems in the United States (U.S.) that impact stakeholders across the healthcare sector, including private, employer-sponsored, and public health plans. Healthcare payers (herein, payers), employer ...

Read More

Pharma & Biotech 2017 – Review of Outsourced Manufacturing PHARMA & BIOTECH 2017 – REVIEW OF OUTSOURCED MANUFACTURING

whitepaper

Jan 26, 2017

This report is an update on the pharmaceutical outsourced manufacturing sector with the last Results’ report published in 2013. By 2015, the global Pharmaceutical market reached $1.11 trillion and is expected to continue growing at approx. 5.5% per annum. Our analysis estimates that the total outsou...

Read More